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ABSTRACT 
 
HEATHER M. SEITZ: The Role of Axl/Mertk/Tyro3 Receptor Tyrosine Kinases in the 
Clearance of Apoptotic Cells 
 
(Under the direction of Dr. Glenn K. Matsushima) 
 
The phagocytosis of apoptotic cells is critical for maintaining normal development, 
tissue homeostasis, and lymphocyte maturation. While this phenomenon is well documented, 
a limited number of receptors have been identified and mechanisms have only been partly 
elaborated. We hypothesized that the Axl/Mertk/Tyro3 family of receptor tyrosine kinases 
are involved in the clearance of apoptotic cells by immune cells. Here we demonstrate that in 
addition to Mertk, Axl and Tyro3 are required for efficient phagocytosis of apoptotic cells in 
macrophages and dendritic cells in vitro. Macrophages rely primarily on Mertk and less on 
Axl and Tyro3; whereas in contrast, dendritic cells rely on Axl and Tyro3 rather than Mertk 
for engulfment of dying cells.  The difference between macrophage and dendritic cell 
phagocytosis can be partly explained by ligand and receptor expression levels. In vivo, Mertk 
is critical for clearance of apoptotic cells in the thymus and retina, whereas in the spleen Axl 
and Tyro3 are most important for engulfment.  Support for cooperation of the receptors in 
signaling can be found in data showing no detectable phosphorylation of Mertk in axl/tyro3-/- 
macrophages. This phosphorylation is thought to be important for downstream signaling of 
Vav1 and FAK to rearrange actin cytoskeleton or phagocytosis and migration.  Indeed in the 
absence of tyro3 or axl/tyro3, there is lower association of Mertk with Vav1, and lower 
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phosphorylation of FAK in the absence of tyro3. Although our data suggests an interaction 
between the three receptors in this family, no interaction was detectable in primary cells or 
transiently transfected cell lines.  The phagocytosis of apoptotic cells is thought to down 
regulate proinflammatory cytokines; however, in the absence of Mertk, Axl, and/or Tyro3, no 
defect in the down regulation of inflammatory cytokines in macrophages was observed when 
compared with wild type.  Therefore, we conclude that usage of Axl, Mertk, and Tyro3 is 
dependent on cell type and is critical for efficient phagocytosis both in vitro and in vivo,
however the downstream signaling initiated by these receptors is limited to engulfment, and 
does not include the down regulation of inflammatory cytokines.  
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CHAPTER 1 
INTRODUCTION 
21.1 The Clearance of Apoptotic Cells 
 The phagocytosis of apoptotic cells is fundamental for normal development, 
lymphocyte maturation, and efficient homeostasis throughout the body.  In development cells 
must specialize into different tissues and remodeling occurs at a high rate. In this process 
apoptotic cells are generated and must be removed efficiently to allow for further 
specialization of the surrounding tissue(1).  In mice, macrophages populate developing 
tissues at the time circulation is established and this pattern is then maintained throughout 
embryogenesis and into adulthood(2).  Additional evidence is seen in Drosophila, where 
CRQ, (the mammalian homologue is CD36) is expressed immediately after the onset of 
apoptosis and its expression is restricted exclusively to the migratory phagocytic hemocytes 
during embryogenesis(3).  Evidence from knockout mice, indicate that phosphatidylserine 
receptor (PSR), a protein thought to recognize phosphatidylserine on apoptotic cells, is 
important for development of the lung and brain tissues.  Failure to do so results in death of 
PSR-/- animals at birth due to lack of oxygenation from underdeveloped lung tissue(4-6).   
It is interesting, that although efficient tissue remodeling in development relies on 
swift clearance of apoptotic cells, many of the proteins involved in this process, with the 
exception of PSR, have been genetically deleted in mice with no resulting defect in 
development.  This makes an important point that although clearance of apoptotic cells is 
critical in development, there are likely many redundant mechanisms to preserve this 
function in phagocytes. Similarly, non-professional phagocytes such as mesenchymal and 
epithelial cells may compensate to ensure efficient clearance in these mutant animals. This is 
illustrated clearly in the PU.1-/- mouse that lacks macrophages, developmental phagocytosis 
3of apoptotic cells is accomplished by mesenchymal cells that compensate for lack of 
macrophages(7).  Although the phagocytosis by these cells is much less efficient, 
development of the footplate proceeds normally. It is not surprising that during development 
and in adult animals that multiple signaling pathways are involved in the phagocytosis of 
apoptotic cells as it is a critical process important in normal development.   
Comparative biology has given insight into the conservation and importance of the 
clearance of apoptotic cells.  In c. elegans there are seven genes that can be linked to defects 
in clearance of apoptotic cells, ced-1, ced-2, ced-5, ced-6, ced-7, ced-10, and ced-12. Very 
similar to the redundancy and complexity seen in mammalian systems, in c. elegans, there 
appears to be two partially redundant groups of proteins that mediate this function, group 1: 
CED-1, CED-6, and CED-7; and group 2: CED-2, CED-5, CED-10, and CED-12. This 
highlights the importance and redundancy of pathways that control this process. Although 
both pathways are required for efficient clearance, deletion studies delineated that group 1 is 
involved in the engulfment process, whereas group 2 participates in both engulfment and in 
migration of gonadal distal tip cells(8). Further, many of the clearance proteins in c. elegans 
have homologues in the mammalian system with the same function, i.e. CED-2 is CrkIII, 
CED-5 is Dock180, CED-12 is ELMO, CED-7 is ABCA-1, and CED-10 is Rac (8).  The 
high evolutionary conservation of the proteins involved in phagocytosis of apoptotic cells is 
additional evidence indicative of its importance.  
 Another area where efficient clearance of apoptotic cells is paramount is in lymphoid 
organs.  In the spleen and thymus, B cells and T cells undergo a highly specialized process of 
selection that ensures specific, non-self lymphocytes proceed to maturation.   In this process, 
it is estimated that 90% of thymocytes do not express a rearranged TCR complex capable 
4of low-affinity interaction with MHC and self-peptide, and therefore fail positive selection 
and die by neglect(9).  Similarly in the bone marrow, immature B cells that bind to self 
antigen die by apoptosis. Further, once in the periphery, B cells in the spleen that are self-
specific or highly activated undergo apoptosis(10). Without efficient removal of these 
apoptotic cells, newly maturing lymphocytes would be bathed in apoptotic and nuclear debris 
that could cause stimulation of autoreactive T and B cells resulting in autoimmune disease.   
 During bacterial inflammation neutrophils are the first responders to pathogen 
invasion.  Neutrophils rapidly phagocytose bacteria and respond by secreting inflammatory 
cytokines to aid in alerting additional innate and subsequently the adaptive immune 
response(11).  However, for inflammation to be resolved, there needs to be a mechanism of 
down regulating this cell type, as they are full of cytotoxic granules and infiltrate in high 
numbers into infected tissues.  Neutrophil responses are partly downregulated by induction of 
apoptosis. This occurs when no cytokines or pro-inflammatory signals are present in the 
normal aged neutrophils population, or as they ingest bacteria and respond to infection in 
acute inflammation(12).  Swift removal of the neutrophils that have undergone apoptosis is 
necessary in order to prevent their release of granules and to ensure that inflammation can be 
resolved quickly.   This efficient removal of apoptotic neutrophils is accomplished by 
macrophages, which are the second responders at sights of inflammation(11, 12).  Therefore 
the efficient phagocytosis of apoptotic neutrophils in addition to other cell types is paramount 
in resolving inflammation and restoring homeostasis to tissues. 
 Different tissues require different strategies to cope with the life cycle of cells and the 
rate of apoptosis and normal cell turnover.  The vast majority of cells that clear these 
apoptotic bodies are tissue specific, i.e.: the epithelial cells, tissue specific macrophages and 
5dendritic cells, and neutrophils.  In organs such as the spleen and thymus, it is thought that 
because of the high number of dying cells, specialized professional phagocytes play an 
important role in keeping the organ clear of dying cells.  This is important to consider, 
because non-professional and professional phagocytes may have very different mechanisms 
of recognition and clearance of apoptotic cells(13).  Non-professional phagocytes, such as 
epithelial cells, endothelial cells, stromal cells of the bone marrow, and nurse cells of the 
thymus, are thought to be much less efficient and may only recognize apoptotic cells at later 
stages of apoptosis than professional phagocytes.   Professional phagocytes such as 
macrophages, dendritic cells, and neutrophils are thought to have highly efficient recognition 
and engulfment machinery that can clear an apoptotic cell before many of the hallmark signs 
of apoptosis are evident.  The large number of phagocytic receptors on macrophages 
compared with non-professional phagocytes supports this hypothesis(14). 
Mechanisms 
 There are many reported receptors on phagocytes and opsonins on apoptotic cells that 
have been implicated in this process (Table 1).  During apoptosis, one of the earliest events is 
the translocation of phosphatidylserine (PS) from the inner leaflet to the outer leaflet of the 
cell membrane.  Although PS exposure is evolutionarily conserved and thought to be a major 
signal for recognition, other changes to the surface of the apoptotic cell are also thought to be 
important in recognition and engulfment. These include the loss of sialic acid residues, 
externalization of oxidized low density lipoproteins, and a putative thrombospondin binding 
moiety(15).   Apoptotic cells can then be opsonized or decorated by binding of GAS6, 
Protein S, and MFG-E8 to PS; or by binding of C1q, mannose binding lectin (MBL), 
6pentraxins, and/or thrombospondin-1directly (16).    These molecular flags act as indicators 
to phagocytes that a cell is undergoing apoptosis and requires immediate engulfment.  
The receptors that are thought to recognize these opsonins or molecular flags include 
integrin v5, calreticulin/CD91, CD14, Class A scavenger receptors, vitronectin receptor 
and Mertk of the Axl/Mertk/Tyro3 receptor tyrosine kinase family(14).  It is yet unclear if 
and how these various receptors and ligands interact and cooperate, or how they might be 
specific to cell types and stage of apoptosis recognition.  Two groups of opsonins have been 
implicated in early and late recognition of apoptosis; PS is thought to be an early marker of 
apoptosis whereas SAP, C1q and MBL binding are thought to occur in later stages of 
apoptosis.  This difference in kinetics may be important for the differential role receptors 
play in various cell types and tissues. Other receptors are reported to bind PS directly, such as 
the Phosphatidylserine receptor (PSR), and Scavenger receptor B1. A thorough 
understanding of which receptors are used by the different and the engagement of multiple 
ligands is lacking.  Studies to address the issue of how cell types utilize each receptor would 
therefore be very informative. 
While recognition and engulfment receptors are seemingly very heterogeneous, i.e. 
their structures and modes of recognition are very different; the signaling that must occur 
downstream is the same for all receptors.   The phagocytosis of most particles including 
apoptotic cells requires activation of the cytoskeletal rearrangement complex involving actin.  
This process is mediated through PI3-kinase activation and recruitment to the cell membrane, 
whereby PI3-kinase can activate guanine-nucleotide exchange factors (GEFs), such as Vav, 
or they may become active through other mechanisms.  Following GEF activation, CDC42, 
Rac, and Rho become GTP bound and activated to recruit CrkII and Dock180 that results in 
7actin rearrangement(17).  Evidence for actin rearrangement involved in all engulfment 
receptors can be seen by inhibition of phagocytosis using cytocholasins that act by 
preventing actin filament assembly and extension. Evolutionary conservation is also further 
evidence of the importance of this signaling cascade. For example, as mentioned above in c. 
elegans, CED-2, 5, and 10 are mammalian homologues of CrkII, Dock180, and Rac 
respectively and similarly facilitate phagocytosis(8).   
Another interesting downstream consequence of phagocytosis of apoptotic cells 
specifically is the down modulation of inflammation.  Under normal circumstances, 
phagocytes that encounter bacteria, particles, or opsonized cells will engage and phagocytose 
that particle. The binding of receptors on phagocytes such as the toll-like receptors then 
elicits an appropriate inflammatory response.  In the case of bacteria or endotoxin, this may 
be a release of TNF-, IL-1, or MIP-1. However, when the same phagocyte encounters an 
apoptotic cell, anti-inflammatory cytokines are released such as TGF-, Prostaglandin-E2, 
Platelet Activating Factor, and IL-10(18, 19).  The effect of phagocytosing an apoptotic cells 
is very strong as it can shut down inflammatory cytokines that have been elicited at the same 
time or after stimulation with apoptotic cells. These include chemotactic cytokines such as 
IL-8 and MCP-1, as well as pro-inflammatory cytokines TNF-, IL-1, and IL-12(20, 21).  
This process is thought to dampen any stimulation of the adaptive immune response and stop 
further recruitment of antigen presenting cells in hopes of preventing any autoimmune 
response.   Investigators are now looking at ways to harness this anti-inflammatory power 
therapeutically and have begun infusing apoptotic cells into patients with inflammatory 
disorders such as Graft vs. Host Disease(22).   
8Clearance of apoptotic cells in animal models of autoimmunity 
 The study of the many receptors and ligands involved in the phagocytosis of 
apoptotic cells have been facilitated by genetically altered animal models.  The consequence 
of the genetic deletion of these receptors has provided insights into function (Table 2).  In 
many of the knockout animals for receptors or ligands of phagocytosis, there is little in vivo 
effect with regards to autoimmunity or gross tissue abnormalities.  For instance, while CD14 
is important in tethering apoptotic cells to the phagocyte, genetic deletion of this construct 
results in phenotypically normal animals with no autoimmunity(23).  In C1q deficient 
animals, there is widespread autoimmunity including auto-antibodies and glomerulonephritis, 
however in murine systems this requires a mixed background of 129/Ola(24).  When c1q-/- 
animals were crossed onto a single C57BL/6 background the autoimmunity phenotype 
disappeared, suggesting that multiple genetic contributions found on the 129 background 
contributed to this phenotype(25).  Phosphatidylserine receptor deficient mice have abnormal 
development characterized by many apoptotic cells in the brain and lungs, resulting in non-
viable animals(4-6).  This suggests that PSR’s role in development is critical compared with 
its function in lymphocyte maturation or homeostasis.  An exception in which deleting genes 
results in autoimmunity is seen in animals lacking the ligand, MFG-E8, or receptors such as 
Mertk, Axl, and Tyro3, where there are auto antibodies and systemic autoimmunity 
suggesting that these are key receptors in the phagocytosis of apoptotic cells(26-28). 
 Further supporting the importance of phagocytosis of apoptotic cells in autoimmune 
diseases, many animal models of systemic lupus erythmatosus have been shown to have 
defects in clearance.  Of the various mouse models, the Fas/lpr mouse and NZB/W mice have 
macrophages defective in clearing apoptotic cells(29, 30).  In addition macrophages from 
9human SLE patients have also been demonstrated to have defects in phagocytosis of 
apoptotic cells(31, 32).  While it is yet unclear the specific role phagocytosis of apoptotic 
cells has in development of SLE, it is certainly correlative and one important element that 
may contribute to the manifestation of the disease.   
A model can be developed where apoptotic cells that are not efficiently cleared may 
induce a microenvironment where inappropriate signals to dendritic cells, macrophages, and 
B cells results in autoimmune disease.  Exposure of the sub-cellular components such as 
DNA, histones, and Sm antigen may lead to the processing and presentation of these self-
antigens to auto-reactive B and T cells.  These lymphocytes could then mediate an auto-
antibody response that causes the inappropriate immune responses to vascular tissue and 
organs leading to the pathogenesis of SLE(10).  Therefore, complete understanding of 
macrophage and dendritic cell function in clearance of apoptotic cells and subsequent effects 
on B and T cells may be an important first step in developing new approaches to treat SLE. 
 A pronounced autoimmunity has been demonstrated in mice deficient in the 
Axl/Mertk/Tyro3 family of receptor tyrosine kinases(27).  Yet the role of this family of 
receptors on macrophages and dendritic cells in the induction of autoantibodies and B cell 
tolerance is not understood.  Previous work from our group has shown that Mertk is critical 
for phagocytosis of apoptotic cells by macrophages and mice deficient in mertk develop 
autoimmunity(28).  Studies using the triple knockout of Mertk, Axl, and Tyro3 reported the 
presence of apoptotic bodies in several tissues, including brain, liver, spleen, and kidney(27).  
Thus the clearance of apoptotic cells in adult animals may rely heavily on Axl/Mertk/Tyro3 
receptor tyrosine kinases and it will be important to define where these receptors operate and 
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to delineate mechanisms that lead to pathology.  The following sections highlight the 
important characteristics to date for Axl, Mertk, and Tyro3. 
 
Table 1 Receptors, Opsonins, and Surface molecules on apoptotic cells that are involved in 
recognition and clearance.  Adapted from (16) 
 
Receptor on Phagocyte Opsonin Binding on Apoptotic Cell References
PSR  PS (6) 
Vitronectin Receptor MFG-E8 PS (26, 33) 
Mertk, Axl, and Tyro3 GAS6 PS (28, 34) 
Tyro3 Protein S PS (35) 
ABCA1   (36) 
Class A Scavenger Receptor  acLDL (37) 
Class B Scavenger Receptor  PS and acLDL (37) 
CD14   (38) 
Calreticulin/CD91 C1q & MBL Calreticulin (39, 40) 
CD36 & Vitronectin Receptor TSP1 TSP Binding Receptor (41) 
Capped CD43 (42) 
PTX3 C1q (43, 44) 
PSR-Phosphatidylserine Receptor, PS-phosphatidylserine, MFG-E8-milk fat globule E8, 
GAS6-growth arrest specific gene 6, ABCA1-ATP binding cassette transporter, TSP-
thrombospondin, PTX3- pentraxin 3. 
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Table 2 Mice genetically modified for receptors or ligands important for phagocytosis of 
apoptotic cells (Modified from Gregory and Devitt, Immunology 2004, 113: 1-14) 
 
Locus Deleted Phenotype References 
c1q or c4 Systemic autoimmunity, increased number of apoptotic 
cells in glomeruli. *** Only on mixed background 
(24, 45) 
mertk, axl, tyro3 Systemic autoimmunity in single knockouts and 
enhanced in triple mutant animals. Autoantibodies, 
splenomegaly 
(27, 28, 46) 
PSR Abnormal development, apoptotic cells in brain and 
lungs. 
(5, 6) 
ABCA1 glomerulonephritis (47) 
MFG-E8 Systemic autoimmunity, autoantibodies. (26) 
CD14 Normal (23) 
PSR-phosphatidylserine receptor, ABCA1-ATP-binding cassette transporter, MFG-E8-milk 
fat globule E8. 
 
1.2 Axl Receptor Tyrosine Kinase  
The Axl receptor tyrosine kinase was discovered in three separate laboratories in 1991.  
Claudio Basilico’s group at New York University isolated “ark” for adhesion related kinase, 
from a library screen of transformed NIH3T3 cells using a cDNA probe of murine bek, the 
receptor for the fibroblast growth factor family(48). Edison Liu’s group at University of 
North Carolina utilized DNA from patients with chronic myelogenous leukemia to transform 
NIH3T3 cells(49) and isolated a similar gene giving it the name axl after the Greek word 
anexelekto, or uncontrolled.  The third group Bartram’s group in Germany, identified a 
similar gene, UFO for it’s unknown function using DNA from patients with a chronic 
myeloproliferative disorder to transform NIH3T3 cells(50).  They isolated and characterized 
the gene and called it UFO for its unknown function.    All authors were attempting to find 
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new kinases that may be involved in transformation of cell lines.  What they found instead 
was a unique kinase, the first in the family to be discovered.   
Axl is a 2826 bp cDNA with the polypeptide encoded by 923 amino acids giving Axl the 
molecular weight of 102 kDa(48).  The extra-cellular domain structure of Axl consists of two 
Ig-like domains followed by two fibronectin type III-like domains.  There are also five 
potential N-linked glycosylation sites in the extracellular domain of Axl.  The 
transmembrane region and an intracellular kinase domain have conserved ATP binding sites 
(537-542), as well as the DLAARN (666-671) and DFGL (684-687) sites that have been 
found in many receptor tyrosine kinases.  Unique to Axl and this family of receptors is the 
amino acid sequence KWAIAES, which although conserved among family members has an 
unknown function to date(48).  The original predictions were that Axl, because of the IgG 
like domains and fibronectin III-like domains, was involved with cell adhesion. While that 
held true, many other functions for this protein have subsequently discovered. 
 The tissue distribution for Axl is widespread.  By Northern blot analysis, axl was found 
to be expressed in murine hematopoetic tissues, breast, tail, uterus, ovary, heart, lung, bone 
kidney, and brain(48).  Further, Axl is highly expressed in tumor cell lines from breast, lung, 
prostatic carcinoma, thyroid carcinoma, and leukemia patients(51-55).  Axl is also expressed 
on macrophages and dendritic cells (Chapter 2 and (56)).    
 The function of Axl has been associated with aggregation, cell growth, 
transformation, and proliferation based on a large variety of systems and cell types.  Early 
work demonstrated that Axl mediated cellular aggregation in a kinase independent manner 
(57, 58).  This data has been refuted in a report that did not find any aggregation affect of Axl 
with or without ligand stimulation in three different human hematopoetic cell lines(59).  
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While the role of Axl in aggregation and adherence appears to be cell line specific, Axl has 
also been implicated in cell growth and proliferation in a number of different systems and 
cell types.  Original observations of Axl were based on it’s ability to transform NIH3T3 
cells(49, 50).  Further, Axl is highly expressed in tumor cell lines from breast, lung, prostatic 
carcinoma, thyroid carcinoma, and leukemia patients(51-55).  In addition, although ligand 
stimulation with GAS6 was only found to be mitogenic in NIH3T3 cells, Axl overexpression 
has a weak mitogenic effect in other cell lines(60).  Furthermore, Axl was found to be 
essential for glioma cell invasion and metastasis, as a dominant negative form of Axl was 
completely inhibitory to tumor formation and invasion(52). 
The widespread expression of Axl did not lend any clues to the putative ligand, 
however studies demonstrated that the ligand for Axl is Growth arrest specific gene 6 
(GAS6).  GAS6 is a serum protein involved in the coagulation cascade and studies have 
shown that GAS6 induces phosphorylation of the Axl receptor in a dose dependent 
manner(61).  This has led to studies of Axl function in vasculature, where endothelial cells, 
pericytes, and smooth muscle cells express Axl.  Axl is reportedly involved in leukocyte 
migration, neointima formation, VEGF signaling in angiogenesis, survival of endothelial 
cells after laminar shear stress, vascular calcification, and flow-induced vascular remodeling 
(62-66).  Many groups have proposed using Axl dominant negative constructs for mediating 
these cellular processes.  Importantly, Axl dominant negative constructs have been used in 
two different tumor models to inhibit signaling and angiogenesis(52).  Further, in an 
angiogenesis model, VEGFR-2 signaling was inhibited by GAS6 stimulation of Axl in 
endothelial cells. This was done through activation of SHP-2, demonstrating that Axl is 
important in downregulating signals including VEGFR-2(63).   These advances shed light on 
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the importance of GAS6 and Axl in regulating angiogenesis and tumor processes beyond its 
role in cell growth and proliferation.  
Axl is post-translationally cleaved by the protease ADAM10, to generate an active 
soluble ECD that is capable of binding ligand.  This may be an important step in Axl 
regulation, or it may serve as another way Axl can activate signaling cascades.  One report 
indicates that Axl is in fact constiutively bound to GAS6 in serum and this may serve to 
regulate the function of both the ligand and receptor(60, 67).  This could be biologically 
significant if Axl bound GAS6 is still able to activate other receptors, or if Tyro3 and Mertk 
require Axl to be bound to GAS6 for efficient signaling and activation.   
Signaling pathways downstream for Axl have been examined in a number of different 
cell types with varying results.  Reports indicate using yeast two hybrid or standard 
immunoprecipitation methods found that Axl interacts with SHP2, Nck2, SOCS1, C1-TEN, 
RanBPM, and IL-15.  Although these proteins have differing functions, many are involved 
with downregulation of cellular responses i.e.; SOCS1, C1-TEN, and SHP2(56, 63, 68).  The 
biological relevance for these interactions is still unclear as these reports have all been in 
various cell lines and functional assays remain lacking.  Many of the reported interactions 
were not ligand dependent and varied among cell lines. The only exception was the IL-15 
interaction that was verified in murine dendritic cells in addition to cell lines.  This 
interaction activated IL-15R and induced protection from TNF- mediated cell death(56).  
Another indicator of Axl being important for downregulation of cellular responses is seen in 
type 1 IFNs suppression of TNF-. GAS6, as well as Protein S and apoptotic cells were 
shown to specifically activate Axl and subsequently activate TWIST to downregulate NF-
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kB(69).  Thus, the function of Axl is complicated and dependent on the presence or absence 
of ligand and cell type expression.   
While much is known about Axl function in vitro, studies in vivo are still lacking to 
determine the impact Axl has on these various cell processes.  There may be a large 
dichotomy between in vitro observations and in vivo function, as axl-/- mice are viable, have 
no vasculature disorders, and are equally susceptible to tumor formation compared with wild-
type mice.  While these mice display enhanced autoantibody production, many of the 
reported functions for Axl have not been verified in these mice. Axl function on immune 
cells has led to very interesting insights into function, however a thorough investigation of 
Axl function in primary cells is lacking.  The data demonstrating that Axl is critical for 
downregulating cytokines and cellular responses is in line with our evidence that this 
receptor is critical for maintaining immune homeostasis and preventing autoimmunity 
(unpublished data). 
 
1.3 Mertk Receptor Tyrosine Kinase 
Mertk was the most recent member of this family to be discovered.  The human isoform 
was originally isolated by Snodgrass’s group at University of North Carolina-Chapel Hill 
from a B lymphoblastoid cDNA library using an anti-phosphotyrosine expression 
cloning(70).  The murine homologue was discovered by the same group, who screened a 
murine spleen cDNA library for homologues of human mer and the chicken viral oncogene 
v-eyk(71).  Wood’s group isolated the same protein by screening a human glioma expression 
library with anti-phosphotyrosine antibodies and found a protein they named Nyk(72).  
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Similarly to Axl, the search for an oncogene led them to Mertk, which plays a role not only 
in oncogenesis but in many other cellular processes. 
The cDNA for Mertk is 3564 bp that translates into 994 amino acids with a molecular 
weight of 110 kDa.  The domain structure of Mertk is consistent with that for Axl and Tyro3, 
including two Ig-like domains and two fibronectin III-like domains extracellularly.  Also 
similar to Axl and Tyro3 the extracellular domain contains 15 N-linked glycosylation sites.  
Intracellularly Mertk, like Axl and Tyro3 contains the consensus ATP binding site (589-594), 
as well as DLAARN (718-723), DGFL (736-739), and the family’s signature sequence 
KWAIAES (760-766) which is unique to this family(71).  
Expression of this receptor tyrosine kinase is widespread with highest expression seen by 
Northern blot heart, brain, lung, liver, muscle, kidney, and testis.  Mertk expression has been 
demonstrated in monocytes, epithelium including the retinal pigment epithelium (RPE), and 
distinct cell types in reproductive tissues(71).  Further, while Mertk is not expressed in 
lymphocytes including B and T cells, T and B cell lymphomas express Mertk at various 
levels.  Mertk is also highly expressed in a variety of other cancers including mantle cell 
lymphoma, B cell leukemia, alveolar rhabdomyosarcoma, gastric, and pituitary 
adenomas(73-78).   
The only known ligand for Mertk is GAS6, similar to Axl.  Also similar to Axl, Mertk 
has been shown to be activated with and without ligand stimulation, therefore the role of 
GAS6 in Mertk activation may be complex.  Protein S, which is a serum protein, expressed 
by a number of cell types appears to bind Tyro3 but not Mertk(79).  Although GAS6 is 
currently the one ligand identified to bind Mertk, the binding dissociation constant of 29nM 
is very weak and it is plausible that other yet unidentified ligands may bind Mertk with 
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greater affinity(80).   GAS6 binds to the other family members, Axl (0.4 nM) and Tyro3 (2.9 
nM) with greater affinity but the functional consequence when all three receptors are 
expressed is not clear.   
Mertk was originally thought to be an adhesion receptor, and while that has been 
demonstrated in cell lines, many other functions for this receptor have been elucidated.  
Initial reports on function for Mertk, demonstrated it’s ability to transform cell lines.  Mertk 
was found to have strong mitogenic and transforming potential in vitro due to high 
expression in cancers and it’s transforming ability.  Further, a truncated form of Mertk with 
the first 210 amino acids removed resulted in a constitutively active form of the protein, this 
autophosphorylation site was carefully mapped and found to be Y749SGDY753Y754R, which is 
a similar site to that of other growth factors including, insulin-like growth factor-1, 
hepatocyte growth factor receptor, platelet-derived growth factor, and colony stimulating 
factor-1 receptor(81).  Another group discovered that the Grb2 site was critical for Mertk’s 
ability to transform cell lines(73).  Mutating Y867 within the Grb2 binding site prevented IL-3 
independent growth in an IL-3 dependent cell line.  As the ligand for Mertk was not yet 
discovered, a chimeric protein was generated with a CD8 extracellular domain fused with 
Mertk intracellular domains (CDMer).  They found that activation of CDMer increased 
activity of MAPK and Erk but this was independent of the Grb2 binding site.  They also saw 
a PI3 Kinase dependent activation of NF-kB upon CDMer stimulation(73).  Thus, the 
multiple phosphorylation sites on the intracellular domain of Mertk suggest many signaling 
pathways are regulated by Mertk. 
 The first in vivo function of Mertk was found after generating the Mertkkd mouse(82).  
This mouse was genetically engineered to have a kinase deficient phenotype, but subsequent 
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studies on the function of Mertk in these animals found that no protein was generated either 
by Western blot or flow cytometry (unpublished data).  The mertkkd mouse has enhanced 
susceptibility to endotoxic shock, in fact the LPS LD100 was ½ that found in wild-type 
mice(82). This was found to be mediated through NF-kB activation and TNF- production, 
as mertkkd animals produce 3 fold higher TNF- than wild-type mice in serum when 
challenged with LPS (82).    
The next in vivo function of Mertk was found in the Royal College of surgeon rat (RCS) 
in which the inherited blindness was found to be due to the mutation in Mertk.  The RPE is 
an epithelial layer in the retina that is responsible for the removal of apoptotic like outer 
segments of growing rods and cones.  Mutations in Mertk prevent the ingestion of these outer 
segments that are shed by the rods and cones and their accumulation destroys the 
homeostasis of the retina.  Subsequently, the mertkkd mouse and humans that possess certain 
mutations in Mertk also are blind and suffer from retinitis pigmentosa.  Thus, Mertk is 
critical for normal maintenance of the retina and preventing retinal degeneration. 
Recently, Mertk was found to influence the clearance of apoptotic cells. This was 
deduced when GAS6, the ligand for Mertk, Axl, and Tyro3 was shown to bind to 
phosphatidylserine on the surface of an apoptotic cell. Therefore, it was hypothesized that 
perhaps another in vivo function of Mertk was in recognition of apoptotic cells.  Our group 
demonstrated in 2001 that macrophages from mertkkd mice were unable to clear apoptotic 
cells. Further, in vivo experiments showed that mertkkd mice were also unable to clear an 
apoptotic cell burden in the thymus and to a lesser extent in the spleen.  Subsequently, we 
reported that these mice were blind and that there was increased autoantibody production in 
these mice(28, 83-87). 
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While Mertk’s function on immune cells has been best characterized on macrophages, 
the role of other family members is only partly known.  There is little data to understand 
which subpopulations of monocytes express Mertk and how this receptor serves to regulate 
these cells.  By examining both macrophages and dendritic cells we hope to provide clues as 
to Mertk’s function in the immune system. 
 
1.4 Tyro3 Receptor Tyrosine Kinase 
The third member of this receptor tyrosine kinase family is Tyro3.  Tyro 3 was found by 
Lemke’s group at the Salk Institute using PCR of a rat peripheral nerve cDNA in searches for 
novel protein tyrosine kinases that regulate neural development.  The cDNA encoding Tyro3 
is 2259 bp that encodes an 875 amino acid protein with a molecular weight of 125 kDa.  
Tyro3, also known as Rse, Sky, brt, and tif, is similar to Axl and Mertk in domain structure 
and size. Extracellularly, Tyro3 contains two Ig-like domains and two fibronectin III-like 
domains.  Intracellularly, the expected ATP binding site (510-515), DLAARN(640-645), and 
DFGL(658-662) sites as well as  the KWAIAES (682-688) unique among these family 
members is found(88).   
Tyro3 is highly expressed in large neurons of adult neocortex, hippocampus, and granule 
cell neurons in adult cerebellum(88).  While expression of Tyro3 is 20-fold higher in neural 
tissues than non-neural tissues, Tyro3 is also expressed in monocytes, epithelium, 
reproductive tissues, and kidney(89, 90).  While Axl, Mertk, and Tyro3 all bind GAS6, 
Tyro3 is unique in its ability to bind Protein S.  While initial reports of this binding were 
across species and therefore disputed. We and others have shown that in the murine system 
Tyro3 does indeed bind murine Protein S(79, 91, 92).   There is evidence that although 
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previous studies using human Tyro3 and human Protein S did not show binding, this may be 
due to the need for Protein S to be in high local concentrations(93).  This could be important 
for receptor activation and regulation as Protein S is found ubiquitously in high 
concentrations in mouse serum, although Tyro3 is not constitutively phosphorylated.  
Requiring a high local concentration of Protein S would allow for Tyro3 signaling to be more 
tightly regulated.  The usage of GAS6 and Protein S is interesting as they have contrary roles 
in the coagulation process.  Protein S is well known to function as an anticoagulation factor 
and functions in the complement cascade, while GAS6 promotes coagulation and clot 
formation. 
The function of Tyro3 has been studied in far fewer systems than that of Axl or Mertk; 
however, a role for Tyro3 in growth and differentiation of cells has been reported.  The 
original report on Tyro3 found that it was able to transform Rat-2 fibroblasts when over 
expressed, similarly to the functions reported for Axl and Mertk(88).  In the cultures of the 
retina, Tyro3 is believed to be important for the phosphorylation of Mertk in RPE which 
presumably triggers proper ingestion of shed outer segments(91).  Data from this dissertation 
suggest that Tyro3 is not critical as deletion of this gene did not result in degeneration of the 
retina (our unpublished data). Another area of Tyro3 function is in bone resorption, where 
Tyro3 is expressed by osteoclasts, and GAS6 and Protein S stimulation caused 
phosphorylation of Tyro3 and increased pit area in a dose dependent manner(61) this was 
also found to be an important mechanism in a model for post menopausal osteoporosis 
caused by estrogen withdrawal in humans(94). 
A role for Tyro3 in immune cells has not been demonstrated singly.  Studies using the 
triple knockout have been helpful in elucidating the function of this receptor, however studies 
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with Tyro3 alone are lacking.  Therefore, it is important to further understand not only the 
expression of Tyro3 on specific immune cells, but its function on these cells. 
 
1.5 The Axl/Mertk/Tyro3 Family 
 Evidence has emerged recently that indicates that Axl, Mertk, and Tyro3 appear to 
cooperate together however; it is still unclear how this cooperation takes place.  Unlike 
mertkkd mice, axl-/- and tyro3-/- mice showed no overt phenotypic abnormalities, but the loss 
of all three receptors has far more devastating consequences.  The triple mutant mouse (axl-/-,
mertkkd, tyro3-/-) was originally generated from three different groups who each donated their 
single knockout.  It is important to keep in mind then, that the studies on these triple 
knockouts came from mice that had three different genetic backgrounds.  The first report 
from these mice demonstrated the function of Axl/Mertk/Tyro3 in spermatogenesis(95).  The 
triple knockout mice are infertile, due mostly to a lack of functional sperm, in addition 
female triple mutant mice have difficulty maintaining pregnancy due to the autoimmune 
environment in these animals(95).   
 A second report highlighted the differences in the immune system in the triple 
knockout(27).   They found enhanced spleen size, apoptotic bodies in virtually every organ 
examined, and high titres of autoantibodies.  They also demonstrated that, while the 
lymphocytes do not express Mertk, Axl, or Tyro3, the triple mutant environment within the 
organs caused the lymphocytes to be hyperactivated.  In addition to this report, the role of 
Axl, Mertk, and Tyro3 in natural killer cell differentiation was demonstrated using the triple 
knockout mouse.  In this report, natural killer cells were found to express all three receptors 
and in the knockout mouse, normal natural killer cell differentiation was impaired(96).  
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Although the tissue expression of these receptors is different, it does overlap in many 
of the systems most affected in the triple knockout.  Macrophages and dendritic cells express 
all three receptors.  However, there are cell types where only one or two receptors are 
expressed, such as Tyro3 and Axl being highly expressed on Sertoli cells, Mertk expressed 
on Leydig cells, and in the retina Mertk and Tyro3 are expressed by retinal pigment 
epithelium whereas Axl is not.  Receptor expression may be an important feature to consider 
when looking at this family of receptors, as the receptors singly, or in combination may have 
different function. 
Another intriguing detail about the three receptors is ligand affinity and usage.  While 
GAS6 has been demonstrated as a ligand for all three receptors, it has markedly different 
affinity for each receptor.  Axl has the highest affinity, followed by Tyro3 and Mertk has a 
much lower affinity for this ligand.  In addition, Tyro3 has been the only receptor shown to 
bind Protein S.  The usage of ligands therefore may be a novel way to understand the 
function of these receptors. 
 The ligands, GAS6 and Protein S are both found in serum and involved in 
coagulation.  This led to studies demonstrating that Mertk, Axl, and Tyro3 are critical for 
thrombus stabilization(97, 98).  Using single knockout mice they found that in the absence of 
one receptor, expression of the other two receptors on the surface of platelets was reduced.  
This lends support to the idea that these receptors associate and function cooperatively(98).  
Additional support comes from the lack of compensation seen in the single knockouts.  In 
platelet aggregation all three receptors are required for efficient thrombus formation. 
 Another model demonstrating a potential association between the three receptors is 
seen in the retina.   The retinal pigment epithelium expresses both Mertk and Tyro3 and 
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Mertk has been shown previously to be essential for efficient clearance of outer segment 
debris by this cell layer(91, 99, 100).  A recent report indicates that signaling through Tyro3 
by Protein S may be critical for efficient clearance by retinal pigment epithelium.  This report 
further supports the notion that without one receptor, expression of the other receptors is 
diminished; as they found lower levels of Tyro3 expressed on Mertkkd retinal pigment 
epithelium(91).  This data, along with data in the platelet model demonstrates that the three 
receptors may have some degree of association.  Therefore studies examining the relationship 
among the three receptors on immune cells may illustrate important features of these 
receptors that are important for maintenance of normal immune homeostasis. 
 
CHAPTER 2 
MACROPHAGES AND DENDRITIC CELLS UTILIZE DIFFERENT 
AXL/MERTK/TYRO3 RECEPTORS IN CLEARANCE OF APOPTOTIC CELLS 
 
Submitted as: Seitz, H. M., Camenisch, T.. D., Lemke, G., Earp, H. S., Matsushima, G. K. 
Macrophages and Dendritic Cells Utilize Different Axl/Mertk/Tyro3 Receptors in the 
Clearance of Apoptotic Cells. Journal of Immunology.
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2.1 Abstract 
The clearance of apoptotic cells is important for regulating tissue homeostasis, 
inflammation, and autoimmune responses.  The absence of receptor tyrosine kinases (Axl, 
Mertk, and Tyro3) results in widespread accumulation of apoptotic cells and auto-antibody 
production in mice.  In this report, we examine the function of the three family members in 
apoptotic cell clearance by different phagocytic cell types.  Mertk elimination nearly 
abolished macrophage apoptotic cell phagocytosis; elimination of Axl, Tyro3, or both, 
reduced macrophage phagocytosis by approximately half, indicating that these receptors also 
play a role.  In contrast, apoptotic cell clearance in splenic and bone marrow-derived 
dendritic cells is prolonged compared with macrophages and relied primarily on Axl and 
Tyro3.  The slower ingestion may be due to lower dendritic cell expression of Axl and Tyro3 
or absence of GAS6 expression, a known ligand for this receptor family.  In vivo,
phagocytosis of apoptotic material by retinal epithelial cells required Mertk.  Unlike 
macrophages, there did not appear to be any role for Axl or Tyro3 in retinal homeostasis.  
Likewise, clearance of apoptotic thymocytes in vivo was dramatically reduced in mertkkd 
mice, but was normal in axl/tyro3-/- mice. However, axl/tyro3-/- mice were unable to clear an 
in vivo apoptotic cell burden in the spleen.  Thus, cell and organ type specificity is clearly 
delineated, with dendritic cells and spleen relying primarily on Axl and Tyro3, retina and 
thymus requiring Mertk, and macrophages requiring all three family members for efficient 
phagocytosis of apoptotic cells.  Surprisingly, in macrophages, tyrosine phosphorylation of 
Mertk in response to apoptotic cells is markedly diminished from axl/tyro3-/- mice, 
suggesting that the interactions of these receptors by heterodimerization may be important in 
some cells. 
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2.2 Introduction 
The phagocytosis of apoptotic cells is important during development, lymphocyte 
maturation, and normal cell turnover.  Without efficient apoptotic cell clearance, dying cells 
accumulate, undergo secondary necrosis, and release intracellular and nuclear contents into 
the extracellular environment.  Released self-molecules may cause lymphocyte activation, 
and autoantibody production(101).  The phagocytosis of apoptotic cells has become an area 
of intense study, and many surface receptors have been implicated in the process of apoptotic 
cell recognition and engulfment(14).  Knockout mice have been generated, deleting many of 
the implicated receptors and intermediate bridging molecules including: CD14, C4, 
Scavenger receptor A, Phosphatidylserine receptor, ABCA1, CD93, Milk fat globule E8 
(MFG-E8), C1q, Vitronectin receptor, and Axl/Mertk/Tyro3 receptor tyrosine kinase 
family(6, 23, 24, 26, 28, 45, 102-106). However, only knockout mice lacking C1q, MFG-E8, 
and Axl/Mertk/Tyro3 receptor tyrosine kinases generate spontaneous autoimmunity(26, 28, 
106). 
 Mertk (also known as Eyk, Nyk, and Tyro-12) belongs to a family of receptor 
tyrosine kinases that include Axl (also known as ARK, Ufo, Tyro-7), and Tyro3 (also known 
as Rse, Sky, Brt, Tif, Dtk)(71).  Each member of the Axl/Mertk/Tyro3 receptor family shares 
a similar extra cellular domain structure and a signature KWAIAES sequence in the 
cytoplasmic kinase domain.   Mertk, Axl, and Tyro3 are widely expressed in adult tissues 
although their function in many of these tissues remains unclear(46).   Mice lacking Mertk, 
or mertkkd (previously known as merkd) mice show spontaneous autoantibody production(28, 
46), splenomegaly, and enhanced TNF- production in response to lipopolysaccharide(82).  
Further, mice lacking all three receptors display a hyperimmune phenotype illustrated by 
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enhanced autoantibody production, splenomegaly and lymphocyte activation greater than that 
seen in mice lacking Mertk alone(27).  One ligand for these receptors is growth arrest 
specific gene 6 (GAS6), which has the highest affinity for Axl, followed by Tyro3 and then 
Mertk (Kd of 0.4, 2.9, and 29 nM respectively)(80).  GAS6 binds to phosphatidylserine on 
the outer leaflet of an apoptotic cell and may serve as a bridging molecule between 
Axl/Mertk/Tyro3 family receptors on phagocytes and the apoptotic cell(107).  The affinity of 
the GAS6/phosphatidylserine complex for Axl, Mertk, and Tyro3 has not been measured.  
Another potential ligand is Protein S, a serum protein involved in the coagulation 
cascade(108), but its role as a ligand for this family is still unclear, as Tyro3 is the only 
family member that binds to Protein S(92).  This finding was made using Tyro3 and Protein 
S from different species and, until now, binding of murine Tyro3 to murine Protein S has yet 
to be reported(79).  However, Protein S binds phosphatidylserine on apoptotic cells and can 
enhance phagocytosis, similar to GAS6(35).  
The enhanced autoimmunity observed in the triple knockout mouse and the higher 
affinity Axl and Tyro3 have for the proposed ligands led us to further investigate the role of 
Axl and Tyro3 in clearance of apoptotic cells in different phagocytes(27, 80).  In this report, 
we demonstrate that Axl and Tyro3 do function in apoptotic cell phagocytosis in both 
macrophages and dendritic cells, but their importance in terms of rate and extent of apoptotic 
cell phagocytosis varies depending upon the cell type.  We also demonstrate that Axl and 
Tyro3 preferentially bind the ligands GAS6 and Protein S respectively and surprisingly, that 
in the absence of Axl and Tyro3, Mertk phosphorylation is markedly reduced in response to 
apoptotic cells.  However, we show that in vivo Mertk, even in the absence of Axl and Tyro3, 
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is fully competent to clear apoptotic cell/material in the thymus and the retina.  Yet the 
spleen relies on Axl and Tyro3 and not Mertk. 
 
2.3 Materials and Methods 
Animals. All mice were housed in specific pathogen-free Division of Laboratory Animal 
Medicine facilities in accordance with IACUC regulations.  Male mice 8-10 weeks old were 
used in studies and wild-type mice are C57BL/6 (Jackson Laboratories and bred in house).  
mertkkd, axl-/- and tyro3-/- mice were backcrossed onto the C57BL/6 background for six 
generations.  Previously designated merkd mice are now designated mertkkd in this report, as 
Mertk is the proper nomenclature.  These mertkkd mice show no detectable protein by 
Western blot or flow cytometry (unpublished results), therefore they are a functionally null 
mutation.  
Macrophage in vitro phagocytosis. Peritoneal macrophages were isolated and phagocytosis 
assay were performed as previously described(28) with the following modifications. 
Peritoneal exudate cells were elicited by intraperitoneal injection with 3 ml of 3% 
thioglycollate (Fisher) for 72 hours followed by lavaging the peritoneum with 3 ml phosphate 
buffered saline.  Resident macrophages were obtained by lavaging the peritoneum of naïve 
mice with phosphate buffered saline.  Peritoneal exudate cells were plated at 1.5x105
cells/well of a 24 well plate.  After 2 hours, non-adherent cells were washed off with PBS 
and fresh macrophage media (RPMI 1640 (Gibco) supplemented with 5% heat-inactivated 
FBS (Gemina Bio-products), 50 units penicillin G and 50 µg ml-1 streptomycin sulphate 
(Gibco), sodium pyruvate (Sigma), and -mercaptoethanol (Gibco)) was added.  The 
resulting adherent peritoneal macrophages were then rested overnight at 37° C with 5% CO2.
29  
To generate apoptotic thymocytes, we collected thymus from naïve wild-type animals and 
dissociated the tissue using forceps.  The single cell suspension was then washed one time in 
PBS and resuspended in macrophage media with 2 µM dexamethasone (Sigma).  After 5 
hours of incubation at 37° C, 2 µM Cell Tracker Green or Cell Tracker Orange (Molecular 
Probes) was added to thymocytes and incubated for 30 minutes, cells were washed with PBS 
and then rested an additional 30 minutes in macrophage media.  Annexin V-FITC (Trevigen) 
and VAD-FMK-FITC staining and analysis by flow cytometry revealed that thymocytes 
were 70-80% apoptotic.  To generate opsonized thymocytes, freshly isolated thymocytes 
were incubated with murine anti-murine CD3 antibody (Serotec) for 30 minutes at 4° C with 
gentle rotation.  After staining, cells were washed 3 times with PBS and then resuspended in 
media.  Addition of fluorochrome-conjugated anti-mouse secondary antibody revealed 
greater than 80% of the thymocytes were labeled with CD3 antibody by flow cytometry.  For 
phagocytosis assays, thymocytes were added at a 10:1 thymocyte:macrophage ratio for 
indicated timepoints.  Macrophages were then washed extensively with phosphate buffered 
saline and fixed with 1% paraformaldehyde (Sigma).  Phagocytosis was determined by first 
counting macrophages in brightfield and then overlaying image of fluorescent apoptotic cells 
to determine the number of macrophages with ingested apoptotic cells.  Only apoptotic cells 
that were completely within boundaries of macrophage were scored as phagocytosed.  200 
macrophages per timepoint in triplicate were counted for each genotype. 
Dendritic cell in vitro phagocytosis. Bone marrow derived dendritic cells (BMDCs) were 
isolated by harvesting femurs from mice and flushing out bone marrow with PBS.  Bone 
marrow cells were then layered on a density gradient of LSM (MP) and centrifuged 500 x g 
for 15 minutes.  The monocyte layer was collected, washed in PBS and resuspended in RPMI 
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1640 (Gibco) supplemented with 10% FBS, 50 units penicillin-G and 50 µg ml-1 
streptomycin sulphate (Gibco), 10 ng/ml GM-CSF, and 10 ng/ml IL-4 (Peprotech). 
Monocytes were plated on low cluster 6 well plates (Costar). On day 3, the media was 
doubled and cytokines were readjusted to 10 ng/ml.  On day 7, immature dendritic cells were 
washed once in PBS and plated in low cluster 24 well plates at 106 cells/well. Splenic 
dendritic cells were isolated using anti-CD11c antibody bound to microbeads (Miltenyi 
Biotec).  Splenic CD11c-positive cells were used immediately for phagocytosis.  Apoptotic 
thymocytes were generated as described above and added to dendritic cells at a 10:1 ratio.  
At indicated time points, the cell suspension was plated on a glass coverslip and dendritic 
cells were adhered for 1 hour.  Non-ingested thymocytes were washed off and dendritic cells 
were stained with anti-CD11c-FITC antibody (Pharmingen).  Cells that were positive for 
both CD11c and ingested apoptotic cells were scored.  To analyse pinocytosis, 1 mg/ml 
Albumin-FITC and 0.5 mg/ml dextran-FITC (Sigma) were added to dendritic cells for 30 
minutes at 37° C or 4° C as a negative control.  Cells were then washed and analysed by flow 
cytometry to determine uptake of albumin or dextran.   
Ligand binding assay and Western Blotting. Axl, Mertk, or Tyro3 extracellular domain- 
Human IgG1 Fc chimeras were purchased from R and D Systems.  10 ng of chimera was 
added to 100 Pl normal mouse serum (Vector Laboratories) or PBS at room temperature for 1 
hour with gentle rotation.  Protein A sepharose (Amersham) was added to chimera/serum 
mixture and incubated an additional 30 minutes at room temperature with gentle rotation.   
For phosphorylation experiments, thioglycollate elicited peritoneal cells were plated 
at 1 x 107 cells per 100 mm petri dish.  After 2 hours non-adherent cells were washed off and 
macrophages were rested for 7 days.  Apoptotic cells were added at 10:1, 
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thymocytes:macrophage, ratio for 15 minutes and then macrophages were washed three times 
with PBS.  Macrophages were lysed using IP lysis buffer (Tris Buffered Saline, 1% NP-40 
(Pierce), 0.1 mg aprotinin, 0.1 mg -1-antitrypsin, 0.1 mg leupeptin (Sigma), 1 mM PMSF 
(Sigma), 2 mM sodium orthovanadate (Sigma), and phosphatase inhibitor cocktails I and II 
(Sigma)) and lysates cleared by centrifugation.  Non-specific proteins bound to sepharose 
were removed by incubating with Protein G sepharose (Amersham) alone for 30 minutes at 
4° C followed by centrifugation.  0.5 Pg anti-Mertk antibody (R and D systems) was added to 
cleared lysate and incubated 30 minutes at 4° C with gentle rotation.  Protein G sepharose 
was added and lysates were incubated an additional 30 minutes at 4° C with gentle rotation.  
Proteins bound to sepharose were isolated by washing three times in lysis buffer. After final 
wash, SDS sample loading buffer was added and the sample was boiled, and resolved on an 
SDS-PAGE gel.  Proteins were transferred onto PVDF membrane (Millipore) and blotted in 
5% milk- Tris Buffered Saline with 0.1% Tween-20 (TBS-T) for 30 minutes.  Primary 
antibody: anti-Protein S (Santa Cruz), anti-phosphotyrosine (Cell Signalling) or anti-Mertk 
(R and D systems) was added at 1:1000 overnight at 4° C.  Blots were washed in TBS-T and 
incubated in anti-goat-HRP (Vector Laboratories) or anti-mouse-HRP (Vector Laboratories) 
for phosphotyrosine blots at 1:10,000 for 2 hours followed by further washing in TBS-T.  
Blots were incubated with ECL-Plus (Amersham) and visualized using Maximum Resolution 
film (Kodak).    
RT-PCR of GAS6 and Protein S. Reverse transcriptase was performed mostly as 
described(109).  Briefly, RNA was isolated from cells using the Trizol (Gibco BRL) reagent 
and 15 ug  of crude RNA was treated with DNAse (Promega).  After isolation, cDNA was 
synthesized for 60 minutes at 42° C using 5 µg RNA with 150 ng random hexamers and 
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MMLV reverse transcriptase (Invitrogen).  PCR was then performed using 50 ng cDNA and 
primers specific for GAS6 (forward 5’ ACAGGCTCAACTACACCCGAACAT 3’ and reverse 5’ 
TGACGGGTGCAGAAATCACCGATA 3’), Protein S (forward 5’ 
CGCCGTCTTGGACAAAGCAATGAA 3’ and reverse 5’ TGCCAGCTGGTGATAGGAATGTGA 
3’), and GAPDH (forward 5’ CTACACTGAGGACCAGGTTGTCT 3’ and reverse 5’ 
GCGAACTTTATTGATGGTATTCAA 3’).  The PCR mixture contained 0.2 mM dNTPs 
and 1.5 mM MgCl2. The PCR products were resolved on a 1.5% agarose gel using 100 bp 
molecular weight standards (Invitrogen). 
In vivo clearance of apoptotic cells and immunohistochemistry. To look at the thymus in 
vivo, adult mice were injected intraperitoneally with 0.2 mg/25 g of dexamethasone (Sigma) 
as previously described(28).  At indicated time points the thymus was removed and half was 
fixed in 10% buffered formalin overnight at 4°C, followed by processing and embedding in 
paraffin.  5 µm sections were cut and stained using the TUNEL method. Briefly, sections 
were deparaffinized with Histoclear (National Diagnostics) and graded ethanol to Tris 
Buffered Saline (TBS), permeabilized in TBS+0.1% Triton X-100 for 5 minutes and nuclear 
material was exposed using Proteinase K.  After washing out detergents and enzyme, 
sections were incubated with dUTP-FITC (Roche) and TdT enzyme (Invitrogen) for 30 
minutes at 37° C.  The other half of thymus was dissociated and stained with VAD-FMK-
FITC (Promega) to detect active Caspase 3 positive apoptotic cells.  These cells were 
analysed on a Becton-Dickinson Facscan cytometer using Summit software.   To examine the 
histopathology of the retina, eyes were removed from adult mice and fixed in 4% 
paraformaldehyde overnight at 4°C.  They were then embedded in paraffin and 5 µm sections 
were cut and stained with hematoxylin and eosin as described previously(110). 
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 To induce apoptosis in the spleen, KLH was injected IP as previously described(26).  
Briefly, 150 µg/25g of KLH in complete Freund’s adjuvant was injected twice, two weeks 
apart and four days after second injection, spleens were collected and snap frozen in OCT.  5 
µm frozen spleen sections were cut and stained for TUNEL as described above.  Tissues 
were analyzed using Image Pro Plus software, counting three fields per mouse, three mice 
per treatment group.   
Statistical analysis. Statistics were calculated using JMPIN 4.0 software (SAS Institute 
Inc.).  Tukey- Kramer HSD One-way analysis of variance (ANOVA) was performed at an 
alpha level of 0.01 or 0.05 to compare all variants in a data set.   
 
2.4 Results 
Mertk is critical for phagocytosis of apoptotic cells by macrophages(28), but the role 
of Axl and Tyro3 has not been adequately studied. Primary peritoneal macrophages were 
isolated and exposed to apoptotic thymocytes.  Greater than 40% of the macrophages from 
wild-type mice ingested apoptotic cells.  In contrast, macrophages from mertkkd mice had a 
dramatic deficit in clearance of apoptotic cells in vitro. Although not as complete, 
macrophages from axl-/-, tyro3-/-, and axl/tyro3-/- mice were significantly less able (by ~50%) 
to phagocytose apoptotic cells when compared to macrophages from wild-type mice (Figure 
2.1D).  Representative confocal images demonstrate the apoptotic cells within the F4/80 
positive macrophages (Figure 2.1A-C).  No phagocytosis was observed in macrophages 
incubated at 4° C or with 2 µM Cytocholasin D indicating that measurements were of 
phagocytosis and not binding (Figure 2.1A-D, H). 
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In order to determine differences in the rate of ingestion, phagocytosis of apoptotic 
cells by macrophages was quantified over a time course. At 60 and 90 minutes macrophages 
from mice lacking axl/tyro3-/- had significantly lower levels of phagocytosis than wild-type 
macrophages (Figure 2.1E).  Macrophages lacking Mertk remained incompetent even at 90 
minutes. To ensure the phagocytosis was not affected by the thioglycollate used to elicit the 
macrophages, we isolated resident peritoneal macrophages and compared phagocytosis.  
Resident macrophages from wild-type mice initiated phagocytosis of apoptotic cells readily 
at 30 minutes and then declined thereafter (Figure 2.1F).  Similar to thioglycollate-elicited 
macrophages, resident peritoneal macrophages from axl/tyro3-/- mice had significant defects 
in phagocytosis at 60 and 90 minutes; although, they exhibited an intermediate response 
between macrophages from wild-type and mertkkd mice (Figure 2.1G).   
Other mechanisms of phagocytosis were examined to determine whether Axl and 
Tyro3 were involved.  Macrophages from wild-type or mutant mice were given latex beads 
(LB) or anti-CD3 antibody opsonized thymocytes (OP).  There was no difference in 
phagocytosis by macrophages from wild-type mice versus macrophages from mertkkd, axl-/-,
tyro3-/-, or axl/tyro3-/- mice (Figure 2.1H).  This indicated that the defect in phagocytosis 
observed in mertkkd and axl/tyro3-/- macrophages was specific for apoptotic cells.   
The mechanism for the phagocytosis of apoptotic cells by dendritic cells is not 
known; however it does not require Mertk(111). We postulated that Axl or Tyro3 might 
function on dendritic cells as receptors important in the recognition and phagocytosis of 
apoptotic cells. Bone marrow from femurs of wild-type and knockout mice was cultured and 
day 7 immature dendritic cells were produced.  There was no difference in co-stimulatory 
molecules CD80, CD86, MHC Class II or CD11c expression on dendritic cells from wild-
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type versus those from mertkkd, axl/tyro3-/- mice (Figure 2.2a).  However, when immature 
bone marrow derived dendritic cells (BMDCs) were co-cultured with fresh or apoptotic 
thymocytes, dendritic cells from wild-type, and mertkkd mice cleared apoptotic cell with 
equal efficiency, while a significant decrease in phagocytosis was observed in dendritic cells 
from axl-/-, tyro3-/-, and axl/tyro3-/- mice (Figure 2.2B-D, E).    Further, while BMDCs from 
axl/tyro3-/- mice never reached levels comparable with BMDCs from wild-type or mertkkd 
mice, BMDCs from mertkkd mice continued to ingest apoptotic cells up to 12 hours after 
being fed (Figure 2.2F).   Confocal images were used to confirm that apoptotic cells were 
within CD11c positive dendritic cells and that the apoptotic cells had not been digested by 
the phagosome (Figure 2.2B-D). 
To ensure that the BMDCs were indicative of those found in vivo, splenic dendritic 
cells were isolated and co-cultured with apoptotic cells.  Similar to BMDCs, splenic dendritic 
cells from axl/tyro3-/- mice had a significant decrease in phagocytosis at 6 hours.  In contrast, 
there was no significant difference between dendritic cells from wild-type and mertkkd mice 
(Figure 2.2G).  A major characteristic ascribed to dendritic cells is pinocytosis where micro-
particles are continuously taken up from the environment for antigen presentation.  To 
determine if this process was altered in mertkkd or axl/tyro3-/- mice, we incubated dendritic 
cells with FITC-conjugated albumin or FITC-conjugated dextran at 37º C or as a negative 
control at 4º C.  There was no significant difference in the uptake of dextran or albumin in 
wild-type BMDCs versus BMDCS from mertkkd and axl/tyro3-/-  mice.  This indicated that 
pinocytosis is normal in BMDCs from mertkkd and axl/tyro3-/- mice (Figure 2.2H). However, 
these data suggest that macrophages and dendritic cells have a fundamental difference in 
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their ability to phagocytose apoptotic cells and this mechanism is mediated by different 
combinations of the Axl/Mertk/Tyro3 receptor family. 
Preferential utilization of the three receptor tyrosine kinases by macrophages and 
dendritic cells may be dictated by the presence of specific ligands.  Due to conflicting reports 
in the literature about whether or not same species Tyro3 and Protein S are binding 
partners(79), we examined whether murine Tyro3 extracellular domain interacts with murine 
serum-derived Protein S.  In these experiments, only Tyro3 extracellular domain interacted 
with murine Protein S, whereas Mertk and Axl had undetectable amounts of protein bound 
(Figure 2.3A).  
The selective usage of Axl/Mertk/Tyro3 receptors by phagocytes prompted an 
examination of whether dendritic cells or macrophages express different ligands. Using RT-
PCR, we found that macrophages express both GAS6 and Protein S, while immature BMDCs 
only express Protein S (Figure 2.3B).  The differential expression of GAS6 and Protein S by 
these phagocytes may partly explain why selected receptors are playing a role in 
phagocytosis. Thus, the expression of both Protein S and GAS6 by macrophages may afford 
engagement of all three receptors, whereas the expression of only Protein S by dendritic cells 
allows preferential interaction of only Tyro3. 
The efficiency with which dendritic cells ingest apoptotic cells is markedly slower 
than macrophages. Dendritic cells require 6-9 hours to reach maximum numbers of ingested 
apoptotic cells (Figure 2.2F) whereas macrophages reach optimum numbers by 60 minutes 
(Figure 2.1E).  One plausible explanation is the relative cell surface expression of Axl, 
Mertk, and Tyro3 on these phagocytes.  Macrophages have high levels of Mertk, Axl, and 
Tyro3 on their surface; mean fluorescene intensities of 22.43, 15.38, and 11.44 respectively 
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(Figure 2.3C-E). In contrast, dendritic cells have low levels of surface Mertk, Axl, and 
Tyro3; mean fluorescence intensity of 2.74, 7.51, and 4.74 compared with macrophages 
(Figure 2.3F-H).  The low levels of Axl, Mertk, and Tyro3 expression on the surface of 
dendritic cells suggest these phagocytes may be less efficient at recognizing and binding 
apoptotic cells; hence, this could correlate with their slower rate of ingestion.  The high level 
of Axl, Mertk, and Tyro3 on macrophages, on the other hand, is consistent with their greater 
efficiency in recognition, binding, and rate of ingestion of apoptotic cells.  
To determine if Axl and Tyro3 are necessary for phagocytosis in other cell types and 
in vivo, we examined the thymus, an organ in which continuous cell death occurs as a 
consequence of maturation and negative selection of thymocytes.  Administration of the 
glucocorticoid dexamethasone to mice induces thymocyte death and provides a model to 
experimentally monitor the clearance of apoptotic cells.  Previously our group has shown that 
mertkkd mice are unable to clear an in vivo dexamethasone-induced apoptotic cell burden in 
the thymus(28).  To determine whether Axl and Tyro3 function as co-phagocytic receptors in 
the thymus, we injected wild-type, mertkkd, axl-/-, tyro3-/-, and axl/tyro3-/- mice with 
dexamethasone and monitored apoptotic cell accumulation in the thymus.  Eight hours is 
when the maximum level of apoptosis is reached in the thymus, and at this timepoint all 
animals had similar numbers of apoptotic cells in the thymus as observed by flow cytometry 
staining and TUNEL staining in tissues (Figure 2.4B and data not shown).  This indicated 
that the induction of apoptotic cells by dexamethasone was similar in all genotypes.   
At 24 hours, as previously shown, mertkkd mice were defective in clearance and 
therefore had an abundance of uncleared apoptotic cells in the thymus as evidenced by 
TUNEL+ staining (Figure 2.4A).  In contrast, in axl-/-, tyro3-/-, and axl/tyro3-/- animals 
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clearance of apoptotic cells was similar to wild-type. Apoptotic cell number in each genotype 
was confirmed by dissociating the thymus and staining for the active caspase-3 marker VAD-
FMK-FITC by flow cytometry (Figure 2.4C).  The fact that the axl-/-, tyro3-/-, and axl/tyro3-/- 
and wild-type mice showed no difference in the number of apoptotic cells indicated that Axl 
and Tyro3 were not required for the clearance of a large burden of apoptotic cells in the 
thymus.  Mertk was both necessary and sufficient in this context.   
 Recently, GAS6 has been implicated in efficient removal of outer segment debris in 
the retina, suggesting that the cognate receptors Axl, Mertk, and Tyro3 may be participating 
in the clearance of outer segments by retinal pigment epithelial cells(112).  In addition, 
mutations in mertk have been linked with retinitis pigmentosa indicating a role for Mertk in 
maintaining normal retinal apoptotic material clearance and suggesting that Mertk functions 
in epithelial cells as well as in macrophages(28, 100).  Retinal pigment epithelial cells 
lacking Mertk cannot clear apoptotic-like outer segment debris.  This results in retinal 
degeneration, and destruction of the outer nuclear layer (ONL) by 6-7 weeks of age(100).  To 
determine whether Axl and Tyro3, which have a higher affinity for GAS6 than Mertk, also 
contribute to retina homeostasis (as they do in macrophages – see Figure 2.2), we examined 
the retina of young and old adult axl-/-, tyro3-/- and axl/tyro3-/- knockout mice.  At two months 
of age, there was no retinal degeneration in normal mice or in axl-/-, tyro3-/-, or axl/tyro3-/- 
mice (Figure 2.5).  The retina of axl-/-, tyro3-/-, and axl/tyro3-/- mice had an ONL of between 
12-14 nuclei similar to wild-type mice.  Furthermore, older axl-/-, tyro3-/-, and axl/tyro3-/- 
mice were without evidence of retinal degeneration at 6 months of age (data not shown). In 
contrast, and as previously reported, mertkkd mice had complete degeneration of the ONL at 
two months of age (Figure 2.5). Thus, the homeostasis of the retina and the clearance of outer 
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segment debris by retinal pigment epithelial cells does not require Axl or Tyro3 and appears 
to rely solely on functional Mertk.  
 Another organ where high numbers of apoptotic cells are generated due to B cell 
activation and maturation is the spleen.  We examined the role of Axl, Mertk, and Tyor3 in 
the clearance of an apoptotic cell burden in the spleen using the KLH model.   We found that 
four days after KLH immunization apoptotic cells were efficiently cleared from wild type 
mice, whereas mertkkd mice had a slight increase in TUNEL positive cells (Figure 2.6).  
Interestingly, axl-/-, tyro3-/- mice had significantly higher numbers of TUNEL positive cells in 
the spleen compared with wild type and this effect was additive in the axl/tyro3-/- double 
knockout.  Thus, in the spleen Axl and Tyro3 are most critical for efficient phagocytosis of 
apoptotic cells, whereas Mertk is not.   
To further examine the cell type specificity, we studied Mertk phosphorylation in 
macrophages stimulated with apoptotic cells.  Macrophages from wild-type mice possessing 
Axl and Tyro3 were able to phosphorylate Mertk at 15 minutes after apoptotic cell 
stimulation.  In contrast, macrophages lacking Axl and Tyro3 had markedly diminished 
Mertk phosphorylation (Figure 2.7).  These results suggest that in macrophages (and perhaps 
other cells), Axl and Tyro3, which have higher affinity for ligand, may be required for 
efficient Mertk tyrosine phosphorylation.  Axl and/or Tyro3 may bind ligand and then 
activate Mertk by heterodimerization similar to ligand-dependent heterodimers found in other 
receptor families (e.g. EGFR family).  Whether this is true in other cells (e.g. retinal 
epithelial cells) in which Mertk seems to function well in the absence of Axl and Tyro3 
remains to be seen.   
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2.5 Discussion 
The efficient clearance of apoptotic cells is paramount for maintaining tissue 
homeostasis.  Patients and animal models of systemic lupus erythmatosus including, NZB/W, 
MRL, and lpr mice have phagocytes that are unable to clear apoptotic debris(29, 30, 113).  
Many genes have been implicated in apoptotic cell clearance, and a subset of these genes 
(such as mfg-e8 and mertk), when deleted, lead to autoimmune phenotypes(26, 28).  Thus, 
the relationship between apoptotic cell phagocytosis and immune homeostasis is important, 
and the exact mechanism by which different phagocytes recognize and ingest apoptotic 
debris merits further study.  Mertk is emerging as a pivotal cell surface receptor that bridges 
innate immune responses and regulation of autoimmune disease, but mice lacking all three 
Axl/Mertk/Tyro3 receptors have an enhanced phenotype compared with mice lacking Mertk 
alone, e.g. autoantibody production, splenomegaly, and lymphocyte activation. This 
prompted further evaluation of the role that Axl and Tyro3 play in the phagocytosis of 
apoptotic cells. 
In this study, we utilized single and double knockout mice for axl and tyro3 to help 
elucidate their function in clearance of apoptotic cells.  Because different organs require 
different cell types to engulf apoptotic debris and maintain tissue homeostasis, we first chose 
two phagocytes that also serve in antigen-presentation and regulate adaptive immune 
responses, macrophages and dendritic cells. Macrophages from mice lacking axl, tyro3, or 
both axl/tyro3, were less efficient in clearing apoptotic cells compared with wild-type 
macrophages (Figure 2.1).  Macrophages from mice lacking mertk exhibited a more dramatic 
deficit in clearance compared with macrophages from mice lacking axl or tyro3 however, a 
50% reduction was significant and comparable to other receptor knockout models (6, 23, 26). 
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In contrast, while dendritic cells from mice lacking mertk had no defect in clearance of 
apoptotic cells (Figure 2.2E-G and (111)), dendritic cells from mice lacking axl or tyro3 had 
a dramatic deficit.  Thus, Axl and Tyro3 are the two receptor tyrosine kinase family members 
that initiate ingestion of apoptotic cells by dendritic cells. Furthermore, later time points 
revealed dendritic cells from mice lacking mertk, had prolonged or extended phagocytic 
activity (Figure 2.2F), perhaps suggesting that Mertk may be playing a role to down regulate 
ingestion by dendritic cells.  This is an important finding as numerous reports link the 
phagocytosis of apoptotic cells by dendritic cells to antigen presentation of apoptotic cell 
material(114). 
In our studies, apoptotic cell phagocytosis by macrophages took only 60 minutes; 
dendritic cells took 6 hours. One plausible explanation for this slower ingestion was the 
lower expression of Axl, Mertk, and Tyro3 in dendritic cells, compared with macrophages 
(Figure 2.3).  It is unclear why receptor usage among these two cell types differs so 
dramatically, but perhaps these discrepancies are correlated with their different functions as 
efficient phagocytes (macrophages) versus professional antigen-presenting cells (dendritic 
cells). We also examined ligand expression for this family of receptors as a potential control 
point and found that while macrophages express both Protein S and GAS6, dendritic cells 
only express Protein S (Figure 2.3B and ref (67)).  This could suggest that dendritic cells are 
more restricted and reliant on Tyro3 for phagocytosis, as Tyro3 was the only receptor shown 
to bind mouse Protein S (Figure 2.3A).  The physiologic roles of Protein S and GAS6, which 
are present in the circulation, is to serve in the natural coagulation system and bind to 
phosphatidylserine on apoptotic cells, platelets, and endothelial cells(115).  In vivo, it is 
certainly possible that the microenvironment of phagocytes contacting apoptotic cells and the 
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selective production of Protein S and GAS6 ligand may dictate engagement of specific 
receptors and partly regulate rates of phagocytosis. 
In tissues such as the thymus, where phagocytes and apoptotic cells are present, we 
examined whether Axl and Tyro3 affect clearance of apoptotic cells. Mertk was critical for 
clearance of an abundant apoptotic cell burden in the thymus, but Axl and Tyro3 were not 
required.  Mice lacking axl, tyro3, or both axl/tyro3 cleared the burden of apoptotic cells as 
efficiently as wild-type mice (Figure 2.5A, C).  It appears that mertkkd mice can clear 
apoptotic cells resulting from the physiologic negative and positive selection of thymocytes, 
as the untreated mertkkd mouse does not exhibit a large excess of apoptotic cells.  It is 
possible that Axl and Tyro3 may be compensating for lack of Mer in mertkkd mice in normal 
homeostasis; however, our data suggest that Mertk is the primary molecule on thymic 
phagocytes critical for clearance of a large synchronous burden of apoptotic cells. It is of 
interest to note that, when all three receptors are missing apoptotic cell removal is hindered 
severely and multiple organs display uncleared apoptotic cells these include brain, testes, 
liver, and lymphoid tissue(27, 95).   
In the retina, we also show that Mertk is critical for maintenance of the retinal tissues, 
whereas deletion of axl, tyro3, or both axl/tyro3 did not result in retinal degeneration (Figure 
2.6).  Furthermore, this observation is consistent with the literature that suggests a mutation 
in mertk is one primary cause of retinal degeneration(99, 100).  These data suggest that 
degeneration of the retina reported in the triple mutant axl/mertk/tyro3-/- mice is primarily 
due to the absence of Mertk(95). A recent report demonstrates Tyro3 expression but not Axl 
expression in retinal pigment epithelial cells; however, our data suggest that Tyro3 is not 
critical for normal maintenance of the retina. 
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We have previously shown that GAS6 triggers Mertk tyrosine phosphorylation and 
downstream activation of Vav1, Rac1, and Cdc42(116).  The complexity and, perhaps, the 
cell type specificity are emphasized by our findings regarding Mertk tyrosine 
phosphorylation in monocytes.  We show in this report that, in macrophages which exhibit a 
role for Mertk, Axl and Tyro3, there may be a need for at least two family members to trigger 
Mertk tyrosine phosphorylation.  Binding of apoptotic cells to macrophages only results in 
robust phosphorylation of Mertk in the presence of Axl and/or Tyro3 (Figure 2.7). We are 
currently investigating whether receptor aggregation is different in macrophages versus 
dendritic cells.  Alternative experiments to identify interaction among the Axl/Mertk/Tyro3 
family of receptors have been difficult due to cross-reactivity of current antibodies; however, 
clues that these receptors act in combination have been demonstrated in triple axl/mertk/tyro3 
knockout mice(27) and in recent studies using platelets, which also express all three receptors 
and appear to require heterodimerization for receptor tyrosine phosphorylation(98).  
Nonetheless, our report is the first to demonstrate multiple members of this receptor family 
are needed for macrophage ingestion of apoptotic cells.   
Figures 2.4 and 2.5 demonstrate that Mertk alone functions in vivo in the retina and 
thymus under normal homeostatic conditions (the retina) or stress-induced burden of 
apoptotic cells (the thymus).  Thus, either Mertk does not require kinase activation for some 
functions or it can function at levels of tyrosine phosphorylation below the limits of detection 
of our in vivo assays.  To test whether there are kinase-independent functions, a “kinase-
dead” Mertk will need to be knocked-in to the Mertk locus and the consequence for retinal, 
thymic, and macrophage apoptotic material/cell clearance assessed.  More likely, 
heterodimerization between Axl, Mertk, and Tyro3 family members is important, but not an 
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absolute requirement.  While the in vitro system (apoptotic cells and isolated macrophages) 
appears to show the need for heterodimers; in vivo Mertk can function well in the absence of 
Axl and Tyro3, perhaps by using other accessory molecules. 
The spleen provided another immune organ to examine the phagocytosis of apoptotic 
cells.  Interestingly we found that Axl and Tyro3, and not Mertk are critical for clearance of 
apoptotic B cells in the spleen (Figure 2.6).  It is interesting to speculate the dendritic cells 
are therefore playing an important role in this organ in clearance.  Previous reports have 
shown that tingible body macrophages are primarily responsible for clearance of the 
apoptotic cells in the spleen and we cannot rule out this cell type in our system.  Further 
studies isolating specific populations of cells from the spleen will elucidate the role of cell 
type and receptor usage in the spleen.  In the spleen axl and tyro3 deficiency appear to have 
an additive effect compared with the single knockouts alone.  This was not observed in 
macrophages or dendritic cells and this may lend insight into the function of these two 
receptors in this organ. 
Many questions regarding Axl/Mertk/Tyro3 receptors and how they function 
differently on different phagocytes remain.  Low levels of these receptors on dendritic cells 
have made detection of protein and phosphorylation difficult; therefore we cannot assess the 
requirement of Axl and Tyro3 for Mertk activation in dendritic cells. MFG-E8 is an 
intermediate protein that facilitates clearance of apoptotic cells in the spleen and is secreted 
by macrophages and dendritic cells and interacts with the integrin V5(117).  Other reports 
have shown that Mertk may also require the integrin V5 for efficient signaling(118).  
Therefore, it remains controversial which combination of receptors, ligands, and signaling is 
required for proper induction of phagocytosis of apoptotic bodies.  In our report we cannot 
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exclude the possibility that integrins may be cooperating with Axl, Mertk, and Tyro3 to 
facilitate this process. Secondly, Axl and Tyro3 appear to have different ligand affinity and 
yet they both are required for efficient phagocytosis by macrophages and most importantly 
by dendritic cells.  Axl is known to be cleaved by ADAM10 and is thought to exist primarily 
as a cleaved soluble form in murine dendritic cells(67).  This soluble form of Axl (sAxl) has 
been found in complex with GAS6 in the serum of mice(67) to the extent that no free GAS6 
was detected.  These studies further indicated that sAxl might enhance GAS6 expression and 
stability.  Therefore a more complex relationship between sAxl/GAS6, Tyro3 and Mertk may 
exist and understanding how this receptor family may interact is an area currently under 
investigation. 
In summary, our report documents a novel role for Axl and Tyro3 receptors in the 
clearance of apoptotic cells and the combinatorial usage by macrophages and dendritic cells 
may provide clues for their biologic relevance.  For macrophages, Axl and Tyro3 appear to 
be important for phosphorylation of Mertk, an event thought to be necessary for rapid 
activation of phagocytosis whereas dendritic cells, which do not require Mertk, are less 
efficient.  The different engagement of this receptor family by macrophages versus dendritic 
cells may be partly dictated by the GAS6 or Protein S expression profile and the level of 
expression of these receptors on phagocytes.  Dendritic cells express lower levels of 
Axl/Mertk/Tyro3 and this is also correlated to slower ingestion rates.  In vivo we have also 
demonstrated that Mertk compensates for the lack of Axl and Tyro3 in the thymus and retina, 
making Mertk most important for these organs in maintaining homeostasis. However, in the 
spleen Axl and Tyro3 are required for clearing an apoptotic cell burden whereas Mertk is not. 
Lastly, the cooperation among this receptor family may be important for efficient signaling 
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as the different receptors have different ligand preference and affinity.
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Figure 2.1 Macrophages lacking Axl and/or Tyro3 have a deficiency in clearance of 
apoptotic cells. A) Representative confocal images of WT B) mertkkd, or C) axl/tyro3-/- 
macrophages stained with F480-FITC and fed Cell Tracker Orange apoptotic cells. D)In vitro 
phagocytosis assay with thioglycollate-elicited PECs collected at 60 minutes after non-
apoptotic (UT, open bars) or apoptotic (AT, closed bars) thymocytes were added. E) 
Thioglycollate-elicited macrophages from wild-type () mertkkd (), or axl/tyro3-/-()
mice or F) resident macrophages were fed apoptotic thymocytes for indicated time points in 
minutes.  G) Thioglycollate-elicited macrophages were fed 2 uM latex beads (LB, closed 
bars) or opsonized thymocytes (OP, open bars) for 60 minutes. WT- wild type  Error bars are 
standard error, n > 3. * p < 0.05, ** p < 0.01. 
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Figure 2.2 Dendritic cells lacking Axl and/or Tyro3 have a deficiency in clearance of 
apoptotic cells. A) BMDCs were stained for CD11c-PE and MHC Class II-FITC, CD80-
FITC, or CD86-FITC and analysed by flow cytometry.  Data is gated on CD11c+ cells.  This 
data is representative of 3 independent experiments. B) Representative image of phagocytosis 
assay, wild-type dendritic cells stained with CD11c-FITC, fed Cell Tracker Orange apoptotic 
cell.  Images were taken on a Zeiss Confocal microscope. BMDCs (C, D) or splenic CD11c+
cells  (E) were fed non-apoptotic thymocytes (UT, open bars) or apoptotic thymocytes (AT, 
closed bars) for 6 hours (C, E) or indicated time points in hours (D) and then plated on 
coverslips. BMDCs from wild-type () mertkkd (), or axl/tyro3-/-() mice. F) BMDCs 
were treated with dextran or albumin at 4°C as a control or 37° C.  Error bars are standard 
error, n > 3. * p < 0.05, ** p < 0.01. 
CD11c 
Figure 2.2 
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Figure 2.3 Binding of Protein S to Tyro-3 and expression of GAS6, Protein S, Axl, 
Mertk, and Tyro3 by phagocytes. A) Mertk, Axl, and Tyro3 extracellular domains fused 
with Human IgG1 Fc domains (R and D systems) were incubated with or without normal 
mouse serum (NMS) and blotted with antibodies specific for Protein S (WB).  B) Detection 
of GAS6 and Protein S by RT-PCR. cDNA was isolated from lung, immature BMDCs, 
macrophages (M	) or a monocyte cell line 32D.  Absence of Taq polymerase (-Taq) is 
negative control for PCR and lack of reverse transcriptase (–RT) is negative control for 
cDNA preparation. Primers specific for GAS6, Protein S and GAPDH were used to examine 
expression by these cell types. MW is a 100 bp ladder. C-E) Thioglycollate-elicited 
peritoneal cells from wild-type mice were isolated and stained with F4/80-FITC 
(Pharmingen) and Mertk (R and D Systems), Axl (Santa Cruz), and Rse (Tyro-3, Santa Cruz) 
antibodies followed by anti-goat-PE (Caltag).  Histograms are gated on F4/80 positive cells.  
F-H) Bone marrow-derived dendritic cells from wild-type mice on day 7 were harvested and 
stained for CD11c (Pharmingen) and receptors as indicated above.  Histograms are gated on 
CD11c positive cells. Shaded sample is isotype control.  Histograms are representative of at 
least three independent cell preparations. 
Figure 2.3 
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Figure 2.4 Mertk is responsible for clearance of apoptotic cells in the thymus. Mice 
were injected with dexamethasone (closed bars) or PBS (open bars) for 8 hours (B), or 24 
hours (A, C) and thymi were collected.  Half the thymus was stained for TUNEL (A) and the 
other half was dissociated and stained with VAD-FMK and analyzed by flow cytometry (B 
and C) WT- wild type, M- mertkkd, A-axl-/-, T-tyro3-/-, and AT-axl/tyro3-/-. Data acquired 
from cytometry was gated on the whole/live cells in the suspension.  Error bars represent 
standard error, n > 4. * p < 0.05 
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Figure 2.5 Mertk is responsible for retina homeostasis. Eye’s were removed from 8 week 
old mice, fixed in 4% paraformaldehyde and embedded in paraffin.  Sections were stained 
with hemotoxylin and eosin to examine morphology. ONL-outer nuclear layer is missing 
from retina in mertkkd mice, arrowhead indicates retinal pigment epithelium.  Images are 
representative of 5 mice of each genotype. Scale bar is 50 microns.  
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Figure 2.6 Axl and Tyro3 are required for in vivo clearance in the spleen. UNT-
untreated mice, KLH-mice immunized with KLH, WT- wild type, M- mertkkd, A-axl-/-, T-
tyro3-/-, and AT-axl/tyro3-/-. Spleens were collected and stained for apoptotic cells using 
TUNEL method.  This is representative of three experiments.  Error bars represent standard 
error.  * p < 0.05, ** p< 0.01 
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Figure 2.7 Axl and Tyro3 are required for efficient Mertk phosphorylation.
Macrophages were incubated with apoptotic cells for 15 minutes and then 
immunoprecipitated for Mer.  Proteins were resolved and blotted with antibody specific for 
phosphotyrosine, stripped and reprobed for total Mer.  This data is representative of two 
independent experiments. WT- wild type, M- mertkkd, and AT-axl/tyro3-/-.
ATWT M
-AC +AC 
WB: anti-Mertk
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CHAPTER 3 
 
ENGAGEMENT OF AXL/MERTK/TYRO3 RECEPTOR FAMILY MEMBERS AND 
THEIR REGULATION OF SIGNAL TRANSDUCTION IN PHAGOCYTOSIS AND 
CYTOKINE PRODUCTION 
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3.1 Abstract 
 Many receptor tyrosine kinases have been implicated as phagocytic receptors for 
apoptotic cells; however, little is known about how these receptors interact and signal for 
engulfment and down regulation of inflammatory cytokines.  As demonstrated in Chapter 2, 
each of the Axl/Mertk/Tyro3 family of receptor tyrosine kinases is critical for efficient 
phagocytosis in macrophages.   The genetic deletion of these receptor tyrosine kinases results 
in autoantibody production, suggesting the importance of these receptors in signaling after 
recognition of apoptotic cells.  Using knockout animals and in vitro cell lines, we 
demonstrate here that Axl, Mertk, and Tyro3 bind to the apoptotic cell. Both Vav1 and v5
have been demonstrated previously to bind Mertk and become activated upon Mertk 
stimulation.  We found that Tyro3 is required for efficient binding of Vav1 to Mertk, but no 
binding of v5 to Mertk was observed.  Downstream of receptor engagement is signaling for 
engulfment through intermediates such as FAK and Akt.  We found that in macrophages, 
Mertk and Tyro3 are required for efficient FAK phosphorylation upon apoptotic cell 
stimulation, however phospho-Akt levels remained unchanged in macrophages deficient in 
Axl, Mertk, or Tyro3.   Lastly, although Axl, Mertk, and Tyro3 are important in activating 
engulfment signals, the down regulation of inflammatory cytokines is not a function of this 
family of receptors.   This is the first report of Axl, Mertk, and Tyro3 function in signaling 
for engulfment in primary cells.  Thus, these data are an important step in understanding how 
Axl, Mertk, and Tyro3 deletion leads to dysfunctions in phagocytosis of apoptotic cells and 
autoimmune disease. 
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3.2 Introduction 
 Receptor tyrosine kinases are important for initiating signaling from a large variety of 
extracellular ligands.  Many receptor tyrosine kinase families share ligands and signaling 
cascades, however there are very few receptor tyrosine kinase families that are known to 
interact.  One such family is the EGF receptor family, which has 4 members that are known 
to heterodimerize to enhance ligand affinity and activation(119).  The Axl/Mertk/Tyro3 
family of receptor tyrosine kinases has been implicated in several biological processes 
including the phagocytosis of apoptotic cells(106).   
Previous reports have shown that the ligands for these family members, Growth arrest 
specific gene 6 (GAS6) or Protein S (PS) bind specifically to phosphatidylserine exposed 
only on the surface of apoptotic cells.  GAS6 and Protein S are thought to then engage Axl, 
Mertk, and/or Tyro3 and enhance phagocytosis of apoptotic cells.  However, little is known 
of how the two ligands, GAS6 and PS, differentially bind and initiate signals through these 
receptors.   
Reports from our group have demonstrated that multiple family members are required 
for efficient phagocytosis of apoptotic cells (Chapter 2).  For example in murine 
macrophages, Mertk is not efficiently phosphorylated in macrophages lacking Axl and Tyro3 
and macrophages from mice lacking axl, tyro3, or axl/tyro3 have a significant defect in 
phagocytosis. Further, in the retina, Mertk can be activated by Tyro3, presumably through 
Protein S signaling(91); however, Tyro3 appears not to be critical as we showed in the 
previous chapter that there is no anatomical deficit in vivo and the eyes of tyro3-/- mice 
appear histologically normal.  This lends support to the hypothesis that these receptors 
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interact with ligand to efficiently signal for the phagocytosis of apoptotic cells; however, the 
usage of each family member is complex and perhaps cell type specific. 
 Previous groups have shown that Mertk can associate with integrin v5 and Vav1 in 
separate in vitro systems upon GAS6 stimulation(116, 118).  Integrin v5 and Vav1 have 
also been demonstrated to be involved in the phagocytosis of apoptotic cells(117, 120).  
Upon phagocytosis of apoptotic cells, the phagocyte must activate the cytoskeletal 
rearrangement complex involving the activation of PI3Kinase, Rac, Rho, and/or FAK, CrkII, 
and Dock180.  In addition, evidence suggesting Mertk and Axl activate PI3K signaling 
cascades further support the notion that these receptors initiate downstream signals important 
for engulfment of apoptotic cells.  It is currently unclear if Axl, Mertk, and Tyro3 are directly 
responsible for initiating this engulfment of apoptotic cells.   
 An important concept that stems from the phagocytosis of apoptotic neutrophils or 
macrophages is the down regulation of pro-inflammatory cytokines(20).  Upon ingestion of 
apoptotic cells, but not foreign material or bacteria, the phagocyte is thought to reprogram its 
activation and initiate signals that shut down a pro-inflammatory cascade of cytokines(20).  
This process has been shown to involve activation of Akt, NF-kB, and subsequently TGF-
expression(19, 121).   Mertk is responsible for the down regulation of TNF- signaling in 
response to LPS stimulation(82).  Because these receptors are involved in phagocytosis of 
apoptotic cells, we hypothesized that Mertk, along with Axl and Tyro3 may have a dual 
function by playing a role in signaling for engulfment and in the down regulating 
proinflammatory cytokines as a consequence to phagocytosis of apoptotic cells. 
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3.3 Materials and Methods 
Chimera binding assays Axl-Fc Chimera, Mertk-Fc Chimera, and Tyro3-Fc Chimera, in 
addition to irrelevant control BAFF-Fc chimeras were purchased from R and D systems.  
Apoptotic cells were generated by isolating thymocytes from naïve mice and treating a 5x106
cells/ml suspension with 2 µM dexamethasone (Sigma) for 6 hours.  Apoptotic thymocytes 
or freshly isolated thymocytes were then washed twice in phosphate-buffered saline (PBS) 
and resuspended in complete macrophage media (RPMI 1640 (Gibco) supplemented with 5% 
heat-inactivated FBS (Gemina Bio-products), 50 units penicillin G and 50 µg/ml 
streptomycin sulphate (Gibco), sodium pyruvate (Sigma), and -mercaptoethanol (Gibco)).  
Chimeric receptors were added at a concentration of 1 µg of receptor per 106 cells for 30 
minutes at 37 C. After binding, thymocytes were washed three times in PBS and incubated in 
1 µg of anti-human IgG1-FITC antibody per 106 cells.  After secondary antibody staining the 
cells were again washed three times in phosphate buffered saline and fixed with 1% 
paraformaldehyde (Sigma) for 15 minutes.  Cells were then analyzed for Fc chimera staining 
on a FACScan cytometer (Becton Dickinson) using Summit 4.3 software.    
For blocking phagocytosis assay experiments, apoptotic or non-apoptotic thymocytes 
were first incubated with 2 µM Cell Tracker Green (Molecular Probes) for 30 minutes, 
washed with PBS and then rested in media for an additional 30 minutes.  Chimeras or 
antibodies were then added at a final concentration of 0.25 µg/500 µl media and incubated 
with wild-type thioglycollate-elicited macrophages at a ratio of 10:1 thymocytes: 
macrophages. To block Fc receptors, anti-CD16/32 (Pharmingen) was added to macrophages 
at a dilution of 1:200 for 15 minutes before addition of thymocytes. Sixty minutes after 
addition of thymocytes coverslips with attached macrophages were washed five times with 
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PBS and fixed in 1% paraformaldehyde.  Three fields from each coverslip done in triplicate 
were counted for total macrophages and number of macrophages that had ingested an 
apoptotic cell.  Phagocytosis is represented as the percent of macrophages ingesting an 
apoptotic cell at 60 minutes. 
Immunocytochemistry. Anti-Mertk antibody was purchased from R and D Systems and 
directly conjugated using the monoclonal antibody labeling kit-AlexaFluor 555 (Molecular 
Probes).  Anti-Axl antibody is from Sigma, and anti-goat-FITC is from Vector.  
Thioglycollate-elicited macrophages were plated on coverslips and allowed to adhere for 2 
hours.  Nonadherent macrophages were washed off and macrophages were allowed to rest 
overnight.  Macrophages were then rinsed briefly in PBS and incubated in staining buffer 
(1:200 Fc Block, 2% normal donkey serum in phosphate buffered saline) for 30 minutes at 4 
C.  Coverslips were then incubated in primary antibody for 60 minutes at 4 C.  For Axl 
staining, cells were washed three times with PBS and anti-goat-AlexaFluor 488 (Molecular 
Probes) was added for 30 minutes at 4 C.  For double staining, Axl-stained coverslips were 
washed after addition of secondary antibody and stained for 30 minutes with directly 
conjugated anti-Mer-AlexaFluor 555 (R and D Systems).  Coverslips were then fixed in 1% 
PFA and mounted using Vectashield with DAPI (Vector Laboratories).  Pictures were taken 
on an Olympus BX40 microscope using a Olympus DP70 camera and analyzed using Image 
Pro Plus 5.0 software. 
Immunoprecipitations and Immunoblotting. For immunoprecipitation (IP) experiments, 
cells were stimulated with apoptotic cells at a 10:1 apoptotic cell: macrophage ratio for 
indicated timepoints, and then lysed in 1 ml/ 107 cells with IP lysis buffer (Tris Buffered 
Saline, 1% NP-40 (Pierce), 0.1 mg aprotinin, 0.1 mg -1-antitrypsin, 0.1 mg leupeptin 
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(Sigma), 1 mM PMSF (Sigma), 2 mM sodium orthovanadate (Sigma), and phosphatase 
inhibitor cocktails I and II (Sigma)).  Insoluble material was pelleted and cleared lysates were 
incubated with IP antibody for 1 hour, followed by addition of Protein G (Amersham) or 
Protein A/G Sepharose (Pierce) to lysates and incubation for an additional hour.  Sepharose 
was pelleted and non-specific proteins washed in lysis buffer.  After the last wash, the entire 
supernatant was removed and SDS loading dye was added, samples were boiled for 5 
minutes and then entire supernatant was loaded onto SDS-PAGE gels.  For whole cell 
lysates, protein was quantified using Biorad’s Dc protein assay and 50 µg of lysate was 
added.   
 After proteins were resolved on SDS-PAGE gels, they were transferred onto PVDF 
membranes and blocked using 5% Milk in TBS-T.  Primary antibodies were added overnight 
at 4 C and secondary for two hours at room temperature.  Blots were developed using ECL-
Plus (Amersham) and HyBlot CL film (Danville).   
Cell lines and transfections CHO-K1 cells were purchased from ATCC, GAS6 expressing 
cell lines were made by stably transfecting CHO-K1 cells with pSEC-TAG2-GAS6 (a kind 
gift from Dr. Shelton Earp), these CHO-K1-GAS6 cells secrete more GAS6 into the 
supernatant than wild-type CHO-K1 as determined by Western blot (Data not shown). For 
immunoprecipitations experiments CHO-K1 or CHO-K1-GAS6 cells were transiently 
transfected using 6:1 Fugene: DNA ratio (Roche).  Axl was isolated from murine kidney 
cDNA and cloned into PCMV-Tag2 (Stratagene). pIRES-EGFP-Mertk was a kind gift of 
Raymond Birge. Tyro3 cDNA was obtained from Dr. Stephen Goff and subcloned into 
pCDNA (Invitrogen).  Cells were immunoprecipitated as described above 48 hours after 
transfection. 
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ELISA and RNAse Protection Assay For ELISA assays, high binding 96 well plates 
(Costar) were coated with anti-cytokine antibody at 100 ng/well in coating buffer (0.1M 
NaHCO3, pH 8.2) overnight at 4 C.  Wells were washed in PBS-T (PBS with 0.05% Tween-
20 (Fisher)) two times and excess PBS-T was completely removed from wells.  Wells were 
then blocked with PBS containing 3% Bovine Serum Albumin (Sigma) for two hours at room 
temperature.  Blocking solution was removed and 200 µl of cytokine containing supernatants 
were added to each well and incubated overnight at 4C.  Wells were washed four times with 
PBS-T and biotinylated cytokine-specific antibody was added at 50 ng/well in blocking 
buffer.  Wells were incubated in antibody for 45 minutes at room temperature, followed by 
six washes in PBS-T.  Avidin-Peroxidase (Pharmingen) was added at 0.5 ug/ml for 30 
minutes at room temperature, followed by washing 8 times in PBS-T.  ABTS substrate (2.2’-
azino-bis (3’ethylbenzthiazoline-6-sulfonic acid) in 0.1 M citric acid, pH 4.35.) was activated 
by adding 10 µl 3% H2O2 to 10 ml of substrate and then immediately added to wells for 30 
minutes.  Plates were analyzed on a   Elx808 Ultra microplate reader (Biotek) at an OD of 
405nm. 
RNAse protection assays were done with the RiboQuant kit probe set mCK-3b from 
Pharmingen.  Briefly, RNA samples were collected using the Trizol reagent, followed by 
DNAse digestion and phenol chloroform purification, and precipitated using isopropanol and 
dried, hybridization buffer was then used to resuspend the RNA, and pre-labeled radioactive 
probe is added to RNA samples, heat shocked at 90 C and then allowed to slowly cool to 56 
C and incubated overnight.  Samples were then cooled to 37 C for 15 minutes and RNAse 
was added to digest non-hybridized RNA.  Proteinase K was then added to inactivate the 
RNAse and the hybridized RNA samples were then purified using phenol chloroform.  
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Ethanol was used to precipitate the hybridized RNA and the complexes were then dried.  
Hybridized RNA was resuspended in loading buffer and loaded onto a 5% acrylamide 
sequencing gel.  Samples were run to resolution using an unhybridized probe set as a ladder.  
After running, the gel was dried and exposed to a phosphorimager screen; data was analyzed 
using a Typhoon 9400 (GE Healthcare) and Molecular Dynamics software.  Samples were 
normalized to GAPDH signal in each lane.  
 
3.4 Results 
 The ligands, GAS6 and Protein S, have been shown to bind apoptotic cells and have 
been shown to bind to Axl, Mertk, and Tyro3, whereas Protein S bound only Tyro3.  No one 
has demonstrated that Axl, Mertk, or Tyro3 bind to apoptotic cells through these 
intermediates.  We therefore wanted to examine the ability of these receptors to bind 
apoptotic cells.  Fc chimeric proteins that contain the extracellular domains of murine Axl, 
Mertk, or Tyro3 fused with the human IgG1 Fc region were used to determine binding.  
These Fc chimeric receptors were added to preparations of non-apoptotic or apoptotic 
thymocytes and then stained with an anti-human IgG1 FITC-conjugated secondary antibody.  
Mertk-Fc, Axl-Fc, and Tyro3-Fc bound the apoptotic cells better than irrelevant controls; 
however, Tyro3-Fc bound to a slightly greater number of apoptotic cells (Figure 3.1A).  This 
is consistent with the ligand binding data suggesting that Tyro3 can bind Protein S in 
addition to GAS6 in order to bind the apoptotic cell(35, 79).  Although specific binding to the 
apoptotic cells was above that observed with control Fc chimera protein, a much higher 
percentage of binding was expected, as our apoptotic cell preparations are ~80% Annexin V-
positive, which indicates phosphatidylserine exposure (data not shown).  The ligands GAS6 
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and Protein S have been shown to bind to phosphatidylserine and potentially bridge with Axl, 
Mertk, and/or Tyro3; however, binding was only ~60% of apoptotic cells.  We can attribute 
this low value to either the number of Fc chimeric molecules added being sub-optimal or the 
different affinity of the Fc chimeras to the GAS6 or Protein S ligand compared to that of 
native Axl, Mertk, or Tyro3 receptor protein.  
 We next utilized these same Fc chimeric molecules to conduct ligand-blocking 
experiments of phagocytosis of apoptotic cells.  We hypothesized that adding these receptor 
tyrosine kinase extracellular domain-Fc chimeric molecules would bind ligand-bound 
phosphatidylserine exposed on the surface of the apoptotic cell. The binding of Fc chimeric 
receptors to apoptotic cells would prevent the macrophages from being able to recognize and 
phagocytose the apoptotic cell efficiently.  Therefore, the Fc chimeric receptors were added 
to the preparation of apoptotic thymocytes for 30 minutes before addition to the 
macrophages.  The percentage of macrophages that had ingested apoptotic cells was contrary 
to expectations.   Although addition of Axl and Mertk Fc chimeras did not significantly 
reduce phagocytosis, the addition of Tyro3 chimera led to a significant increase in the 
number of macrophages that had ingested apoptotic cells (Figure 3.1B).  This was surprising, 
as the human Fc region in the Fc chimeric receptors were not expected to bind to murine Fc 
Receptors on macrophages.  However, to rule out the possibility that Fc receptors were 
playing a role, anti-CD16/32 (Fc
R) antibody or Fc Block was added to the phagocytosis 
assay (Figure 3C).  This antibody specifically binds to the Fc 
 receptor and subsequently 
prevents the capture of other antibodies.  The addition of Fc Block to the phagocytosis assay 
reduced the levels of phagocytosis of apoptotic cells that were bound with Tyro3 Fc chimeric 
protein to wild-type control levels (Figure 3.1C).  If the Fc regions of each chimera bound 
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equally to the Fc receptors found on these macrophages, then this suggests that the Tyro3-Fc 
chimera bound to more apoptotic cells than Axl and Mer-Fc chimeras.   
 An alternative method to block receptor binding is through the use of antibodies to 
either the ligand or receptor.  In order to demonstrate which receptor and ligand was most 
critical for phagocytosis of apoptotic cells antibodies to Mertk, Axl, or Tyro3 were added to 
cultures containing macrophages from wild-type mice and apoptotic thymocytes (Figure 
3.1D).  These antibodies showed no significant reduction in the ability of macrophages to 
ingest the apoptotic cells. Similarly, anti-GAS6 or Protein S-specific antibodies were added 
to the phagocytosis assays in an attempt to block these interactions by occupying the ligand 
(Figure 3.1E).  Our results were not conclusive; however, as no significant blocking of 
phagocytosis was observed with any antibody used (Figure 3.1E).  As these blocking 
antibodies are polyclonal antibodies, it is plausible that the amount of antibody to the critical 
epitopes responsible for binding would be very small and may be inappropriate for blocking 
these.  Therefore, these studies are inconclusive and do not demonstrate which receptor or 
ligand was most important for phagocytosis. 
 Tyro3 has the highest affinity for the apoptotic cell based on the Fc chimera studies 
done above.  This is interesting, as the mertkkd mouse has macrophages that are completely 
unable to phagocytose apoptotic cells, whereas axl-/- and tyro3-/- mice have macrophages that 
are only partially deficient in phagocytosis (Chapter 2).  This data, along with data from 
other groups showing that in the retina, Tyro3 is required for efficient Mertk function, 
suggests that perhaps these receptors interact to efficiently phagocytose apoptotic cells.  In 
order to study this, we first examined whether the receptors were found on the same cell.  We 
have previously demonstrated by flow cytometry that Axl, Mertk, and Tyro3 are all 
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expressed on macrophages and dendritic cells (Chapter 2); however, all commercially 
available antibodies that have been shown to be specific are produced in goats.  This has 
prevented double-staining by flow cytometry to determine if the three receptors are co-
localized on the same cell.  An alternative approach was to directly conjugate the receptor-
specific antibodies to avoid using a secondary antibody that was directed against goat Fc.  
The first attempt to directly conjugate the Mertk antibody to a FITC fluorochrome caused the 
antibody to no longer be specific and was determined to be unusable.  Therefore, we directly 
conjugated this antibody to Alexa Fluor-555 (AF-555).  This AF-conjugated antibody was 
shown to retain specificity and was able to bind and detect Mertk on the surface of 
macrophages on coverslips as well as in fresh frozen, acetone-fixed sections (Figure 3.2A 
first panel and data not shown).  Macrophages were also stained with anti-Axl antibody in the 
second panel and co-staining of macrophages for Axl and Mertk suggested that these two 
receptors are on the same cell (Figure 3.2A overlay in the third panel). Unfortunately, the 
three commercially available anti-Tyro3 antibodies were not specific when compared with 
tyro3-/- cells and these antibodies could not be used to determine if Tyro3 co-stained with 
Mertk and/or Axl.   Furthermore, Axl and Mertk can be found singly on ~70% of 
macrophages, whereas coexpression of both receptors was seen on ~70% of macrophages.   
 In order to determine whether or not Axl, Mertk, and Tyro3 interacted in primary 
cells, coimmunoprecipitations were conducted on murine thioglycollate-elicited 
macrophages.  Immunoprecipitation of one of the receptors and Western blotting for an 
associating receptor proved difficult due to the antibody reagents.  Unfortunately, in 
optimizing this assay, it was determined that the antibodies against Axl and Tyro3 were 
nonspecific.   In Figure 3.2B, titration of the amount of immunoprecipitating antibody to 
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reduce the non-specific bands detected by Western for Mertk antibody was successful; 
however Axl and Tyro3 antibodies could not be titrated effectively.  Further, by titrating the 
immunoprecipitating antibody, we were concerned about losing detection of potential 
interacting receptors, as immunoprecipitating antibody should always be in excess of the 
target.  These preliminary immunoprecitpitation experiments demonstrated that primary cells 
could not be used to determine if interactions between these receptors exists.  
A second approach to determine receptor interaction was to produce transfected cell 
lines with Axl, Mertk, or Tyro3 receptors, tagged with either FLAG epitopes or Myc 
epitopes, singly or in combination and used anti-FLAG or anti-Myc antibodies to detect 
interactions among the receptors.  Therefore CHO-K1 cells expressing wild-type levels of 
GAS6 or CHO-K1 cells stably expressing higher levels of GAS6 were transfected with 
various combinations of the receptors i.e. Axl-FLAG and Mertk, Axl-FLAG and Tyro3 or 
Tyro3-FLAG and Mertk.  We saw ample expression of all three constructs in the cell lines 
used (bottom panels of Figure 3.2C); however, we detected no interaction between the 
receptors by immunoprecipitation (top panel of Figure 3.2C).  Although Axl and Tyro3 
interactions were examined in Figure 3.2C, all other combinations of receptors were tried, 
and no interaction was seen in any combination of receptor expression (data not shown). 
 Previous reports on Mertk have demonstrated an in vitro interaction between Mertk 
and v5 integrin(118).  Further a report by Mahajan and Earp suggests that Vav1 is 
constitutively bound to Mertk and upon stimulation Vav1 is phosphorylated and released 
from Mertk, presumably to signal Rac, Rho, and Cdc42(116).  These previous experiments 
were done in NIH3T3 or 32D cells with chimeric Mertk constructs. In light of these reports, 
we wanted to investigate a role for Mertk in integrin and Vav1 signaling in primary 
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macrophages as part of the cascade leading to cytoskeletal rearrangements and phagocytosis.  
Primary murine macrophages were stimulated with apoptotic cells for 15 minutes and then 
immunoprecipitated for Mertk.  Western blots were conducted to determine whether Mertk 
associated with Vav1 in primary macrophages (Figure 3.3A).  In unstimulated wild-type 
macrophages, there was no detectable Vav1 bound to Mertk (Figure 3.3A lane 1); however 
upon stimulation, Vav1 associates with Mertk at 15’ (Figure 3.3A lane 5).  In apoptotic cell 
stimulated macrophages, the absence of Tyro3, or Axl and Tyro3 resulted in very low but 
persistent levels of Vav1 bound to Mertk (Figure 3.3A lane 3, 4, 7, and 8).  Therefore, 
although, Vav1 associates with Mertk in wild-type macrophages, we saw significantly less 
Vav1 association with Mertk in macrophages deficient in tyro3 or axl/tyro3.
We then examined whether v5 associated with Mertk. This experiment was based 
on reports of Mertk binding v5 in the NIH3T3 cell line.  Therefore we used 
immunoprecipitations with anti-Mertk antibodies to look for interaction by Western blot for 
5. Macrophages were stimulated with both recombinant GAS6 (Figure 3.3B middle) or 
apoptotic cells for 15 minutes (Figure 3.3B right).  Independent of stimulus used, we found 
no detectable v5 interaction with Mertk in primary murine macrophages.   
 Upon binding and phagocytosis of apoptotic cells, the macrophage initiates signaling 
cascades leading to actin cytoskeletal rearrangement.  It is well documented that this process 
involves Rac, Rho, PI3K(21).  There are also reports of FAK and Ikk/ activation being 
required for efficient engulfment of apoptotic cells(117, 121).  Because Axl, Mertk, and 
Tyro3 are critical for phagocytosis of apoptotic cells, we wanted to understand whether these 
receptors were responsible for activating the cytoskeletal rearrangement pathway.  To 
determine the role of FAK, thioglycollate-elicited macrophages from wild-type or knockout 
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mice were then stimulated with apoptotic cells to measure phosphorylated FAK.  In wild type 
macrophages, there was a large increase in phosphorylated FAK upon stimulation with 
apoptotic cells compared to unstimulated macrophages (Figure 3.4A lane 1 and 2).  Further, 
macrophages deficient in Mertk or Tyro3 had less phosphorylated FAK than wild-type 
macrophages (Figure 3.4A lane 3 and 4, and lane 7 and 8).  Macrophages deficient in Axl 
showed no decrease in phosphorylated FAK upon apoptotic cell stimulation, suggesting that 
Axl may not be responsible for FAK phosphorylation.  This data demonstrates that Mertk 
and Tyro3 are important for FAK phosphorylation upon apoptotic cell stimulation.   
Another molecular intermediate in this pathway that is involved in cytoskeletal 
rearrangement is PI3K activation.  A downstream indicator of PI3K activation is an increase 
of phosphorylated Akt.  In addition, phospho-Akt that leads to NF-kB activation and 
activation of NF-kB has been shown to be critical for the regulation of proinflammatory 
cytokines. We therefore examined macrophages for differences in pAkt levels after 
stimulation with apoptotic cells (Figure 3.4B).  No differences were found between 
macrophages from wild-type and axl-/-, mertkkd, tyro3-/-, or axl/tyro3-/- mice in their ability to 
phosphorylate Akt. This contradicts data in dendritic cells that demonstrates a role for Mertk 
in activation of Akt upon GAS6 or apoptotic cell stimulation(121). 
Lastly, one of the most important downstream effects of phagocytosis of apoptotic 
cells is the down regulation of inflammation.  It is well documented that macrophages that 
have ingested apoptotic cells secrete anti-inflammatory cytokines such as TGF- and IL-10, 
whereas the production of pro-inflammatory cytokines, even in the face of strong pro-
inflammatory signals such as microbial pathogen associated molecular patterns (PAMPs) is 
shutdown(19).   Examples of PAMPs used here are lipopolysaccharide (LPS) from Gram-
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negative bacteria, peptidoglycan (PGN) from Gram-positive bacteria and zymosan from 
yeast.  As the regulation of cytokines is an important process, we wanted to examine the role 
of Axl, Mertk, and Tyro3 in the down regulation of inflammation. First a dose titration was 
needed to determine the optimal concentration of pro-inflammatory stimulus without 
oversaturation and excessive activation of the macrophages that would make down regulation 
difficult to observe. Therefore, we titrated doses of LPS (Figure 3.5A), PGN (Figure 3.5B), 
and zymosan (Figure 3.5C) on macrophages from wild-type, mertkkd, axl-/-, tyro3-/-, and 
axl/tyro3-/- mice and examined TNF- production.  There were no significant differences 
observed in the levels of TNF- produced in response to these microbial PAMP’s in the wild 
type or knockout mice (Figure 3.5A-C).  Titration of the number of apoptotic cells needed to 
inhibit pro-inflammatory cytokine production required determination; therefore, we treated 
macrophages with a fixed dose of LPS, and then increased the number of apoptotic cells.  
The amount of TNF- could be titrated down consistently with increasing numbers of 
apoptotic cells, and we found that a 40:1 ratio of apoptotic cells to macrophages gave 
complete inhibition of TNF- production (Figure 3.5D).  Further, there were no significant 
differences in the amount of TNF- produced in the macrophages from knockout mice 
compared with wild-type mice. This was confirmed by examination of the amount of TNF-
RNA (Figure 3.5E).  In RNAse Protection Assays (RPA), TNF- RNA in macrophages 
increased upon stimulation with LPS.  In contrast, the addition of apoptotic cells to the 
cultures dramatically inhibited expression of TNF- RNA. This inhibition of TNF- by 
addition of apoptotic cells was consistent with what we found in secreted protein in ELISAs 
(Figure 3.5D).  
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The phagocytosis of apoptotic cells results in the secretion of TGF-. In Figure 3.5F, 
the addition of apoptotic cells to LPS-stimulated macrophages resulted in the secretion of the 
anti-inflammatory cytokine TGF-. Although in our experiments, macrophages deficient in 
Mertk or Axl/Tyro3 showed a reduction in TGF- RNA after ingestion similar to wild-type. 
This suggests that although Axl, Mertk, and Tyro3 play a role in downstream 
signaling pathways involved in the engulfment of apoptotic cells, they are not required for 
cytokine regulation.  The possibility exists however, that the receptors are able to compensate 
for the lack of one or two of the family members.  Therefore, it is plausible that all three 
receptors must be eliminated in order to conclude whether cytokines are not regulated by 
these receptors and the triple knockout on a backcrossed C57BL/6 background mouse has yet 
to be generated.   
 
3.5 Discussion 
 The proposed model of GAS6 or Protein S binding to the apoptotic cell, coupled with 
engagement of Axl, Mertk, and Tyro3 has not been directly demonstrated.  Thus, no binding 
of Axl, Mertk, or Tyro3 to apoptotic cells has been shown.  We attempted to look at the 
receptors binding affinity for apoptotic cells by utilizing Fc chimera constructs.  We found 
that Tyro3 bound to a greater number of apoptotic cells, followed by Axl and Mertk (Figure 
3.1A).  Unfortunately the percent binding we observed was lower than expected values based 
on the percent of apoptotic cells in the population.   The apoptotic cell preparations are 
routinely 80% Annexin V positive; however, we saw only 60% of apoptotic cells bound to 
the receptor Fc chimeras.    Therefore more experimentation is needed to confirm the finding 
that Tyro3 binds a larger number of apoptotic cells than Axl and Mertk.   This data makes 
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sense in light of the higher affinity of GAS6 for Axl and Tyro3 and it is plausible that Tyro3 
may be binding to it’s alternative ligand, Protein S. Thus, Tyro3 could be using two ligands 
and thus increasing binding opportunities to apoptotic cells whereas Mertk or Axl 
presumably use only GAS6 that may present fewer interactions.  In order to study this 
further, constructs should be made that do not have an Fc portion, to rule out any nonspecific 
binding due to differences in this part of the protein.  Also, titrations with varying numbers of 
receptor and cells should be done to ensure that we are at saturating concentrations.  Lastly, 
competitive binding with excess GAS6 and Protein S would be useful in delineating the role 
of these two intermediates in binding to the apoptotic cell. 
The second method to study binding of Axl, Mertk, and Tyro3 with apoptotic cells 
was by blocking phagocytosis using the Fc chimeras and antibodies.   We found that 
although no appreciable blocking was seen using any ligand antibody or Fc chimera 
construct, we found higher percent of phagocytosis in samples that contained Tyro3-Fc 
(Figure 3.1B-D).  This data suggests that Tyro3 may be binding the apoptotic cell better than 
Axl or Mertk and then acting through Fc receptor-mediated phagocytosis to actually enhance 
phagocytosis.  Since the Tyro-Fc chimera bound the surface of apoptotic cells similar to Axl-
Fc or Mertk-Fc chimera (Figure 3.1A), we presume the higher phagocytosis with the Tyro-Fc 
chimera could be due to greater binding opportunities that results in increased tethering of the 
apoptotic cell to the macrophages to facilitate engulfment.  We found that Fc receptor-
mediated phagocytosis resulted in the increase of Tyro3-Fc ingested apoptotic cells and the 
inclusion of an antibody to block Fc receptor returned phagocytosis to wild-type levels 
(Figure 3.1C).  These experiments should also be confirmed using constructs that do not 
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contain Fc regions.  Nonetheless, these data suggest that Axl/Mertk/Tyro3 receptors can bind 
apoptotic cells along with other recognition receptors.  
Data in Chapter 2, in addition to published reports in platelets and retina, suggest that 
these family members may interact for efficient signaling(91, 98).  Therefore, we examined 
this interaction by first looking at Axl, Mertk, and Tyro3 expression on macrophages. We 
found that wild-type macrophages express both Axl and Mertk (Figure 3.2A). Unfortunately, 
cross-reactivity among the antibodies caused problems that prevented co-localization of 
Tyro3 with the Axl and Mertk receptors on macrophages.  For further confirmation that 
receptors are co-localized on the same cell and could perhaps interact with one another, 
immunoprecipitations for the receptors was conducted. Unfortunately, crossreactive 
antibodies prevented examining interactions in primary cells (Figure 3.2B).  We therefore 
attempted to examine receptor interactions in cell lines transfected with tagged constructs.  
Again we saw no interaction using tagged constructs (Figure 3.2C).  This led us to the 
conclusion that these receptors do not interact, or do so transiently.  Further experiments 
using crosslinking reagents will delineate if the interaction is transient. 
Previously published work suggests that Mertk binds to Vav1 and the integrin v5
in a ligand inducible manner(116, 118).  These studies were done in cell lines and used 
chimeric constructs with artificial ligands so it is questionable whether this occurs in primary 
cells.  We therefore wanted to confirm these findings in primary cells.  We found that Mertk 
does indeed transiently associate with Vav1 upon apoptotic cell stimulation, and this 
interaction requires Tyro3 (Figure 3.3A). We did not see interaction with v5 upon 
stimulation with GAS6 or apoptotic cells (Figure 3.3B).  This data suggests that Mertk’s 
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primary role upon apoptotic cell stimulation in macrophages may be to activate Vav1 and not 
interact with v5.
FAK is downstream of integrin signaling and has been demonstrated to be important 
in actin cytoskeletal rearrangement.  Although we found no association of Mertk and v5,
we did see a difference in FAK activation upon apoptotic cell stimulation in wild-type 
compared with mertkkd macrophages.  Further, tyro3-/- macrophages also had less 
phosphorylated FAK than wild-type, whereas axl-/- macrophages had similar levels to wild-
type (Figure 3.4A). While this is a discrepancy, there are other signaling intermediates 
besides integrins that can activate FAK in macrophages and thus this warrants further 
investigations.   
Downstream of phagocytosis is PI3Kinase activation. PI3K signaling is important in 
actin cytoskeletal rearrangements as well as cytokine regulation. Because apoptotic cells 
have been shown to down regulate pro-inflammatory cytokines, we wanted to examine the 
PI3Kinase activity to determine if Axl, Mertk, or Tyro3 played a role. All three receptors 
presumably have a PI3K domain in their cytoplasmic tail.  We found that there was no 
difference in phosphorylated Akt, a key signaling protein in the PI3kinase pathway. Further, 
Akt was not activated in macrophages upon stimulation with apoptotic cells alone in our 
hands (Figure 3.4B).  This contradicts data seen in dendritic cells suggesting Mertk does 
signal through Akt in response to apoptotic cells.  Explanations for the discrepancy are cell 
type, we used macrophages whereas Sen et al used dendritic cells, in addition to a different 
genetic strain of mouse our mice are backcrossed onto C57BL/6 background whereas Sen et 
al used mice on a Non-Obese Diabetic mouse background (NOD)(121). 
74  
As mentioned, down regulation of proinflammatory cytokines is an important 
downstream consequence of phagocytosis of apoptotic cells. Due to the role Axl, Mertk, and 
Tyro3 play in this process, we wanted to examine their role in cytokine regulation. We found 
that this family of receptors is not required for downregulation of proinflammatory cytokines 
and is somewhat contrary to the role suggest by earlier studies with Mertk(82). This was 
demonstrated by RNA and protein to ensure that regulation was happening at both steps 
(Figure 3.5).  
Thus, we conclude that the receptor family members participate in recognizing 
apoptotic cells and that Tyro3 may have the greatest affinity for binding and tethering the 
apoptotic cell to the phagocytes.  We have demonstrated that the engagement of apoptotic 
cells results in activation of Vav1 and may trigger FAK activity but appears not to activate 
Akt.  However, the signaling pathway for phagocytosis appears to be independent from the 
regulation of cytokines.  In fact, our data suggest that Axl/Mertk/Tyro3 receptors are not 
required for down regulation of proinflammatory cytokines. 
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Figure 3.1 Axl, Mertk, and Tyro3 bind to apoptotic cell. A) Flow cytometry data showing 
Fc chimera receptor constructs binding to apoptotic thymocytes.  B) Blocking of 
phagocytosis with Fc chimera’s M- Mer Fc chimera added; A-Axl Fc Chimera; and T-Tyro3 
Fc Chimera; non is non-apoptotic cells added to macrophages in absence of chimera, and 
apop is apoptotic cells added to macrophages C) Phagocytosis assay using Fc Block to 
prevent phagocytosis of Tyro3-Fc chimeric protein bound to apoptotic cells (AC).  D) Anti-
receptor antibody blocking phagocytosis assays. E) Anti-ligand antibody blocking 
phagocytosis assays. PS-Protein S IC-isotype control for blocking antibody, AC or UNT-
apoptotic cells alone NAC-non-apoptotic cells. Flow data is representative of two 
experiments, phagocytosis assay data is representative of three experiments. 
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Figure 3.2 Axl/Mertk/Tyro3 receptors do not interact on macrophages. A) Immuno-
cytochemistry of peritoneal macrophages. Left panel- wild-type macrophages stained with 
anti-Mertk-AlexaFluor 555, middle panel- macrophages stained with anti-Axl and secondary 
antibody anti-goat AlexaFluor 488, right panel is overlay indicating macrophages expressing 
both Mertk and Axl (yellow).  20x field.  B) Immunoprecipitation on primary macrophages. 
Wt-wild-type; kd-mertkkd; and ko-knockout (second panel is Tyro3 knockout, and third panel 
is Axl knockout).  IP-immunoprecipitate, WB-Western blot. C) CHO-K1 or CHO-K1-GAS6 
cells transfected with indicated constructs and immunoprecipitated for tagged protein. Data is 
representative of Axl/Mer co-transfections, and Mer/Tyro co-transfections. WCL-whole cell 
lystae of transfected cells. 
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Figure 3.3  Mertk association with Vav1 requires Tyro3. A) Macrophages were 
stimulated with apoptotic cells for 15 minutes, and then immunoprecipitated for Mertk. 
Proteins were blotted for Vav1, stripped and reprobed for total Mertk.  B) Macropahges were 
stimulated with apoptotic cells or recombinant murine GAS6 for 15 minutes and then 
immunoprecipitated for Mertk. W-wild-type  A-axl/tyro3-/- Proteins were blotted for beta5 
integrin, stripped and reprobed for total Mertk. 
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Figure 3.4 Mertk and Tyro3 are required for efficient FAK phosphorylation upon 
apoptotic cells stimulation. A) Macrophages were treated with or without apoptotic cells 
(AC) for 15 minutes, after washing off unbound AC, whole cell lysates were blotted for 
phosphorylated FAK at tyrosine 861, p861Y-FAK.  Blots were stripped and reprobed for 
total FAK. B) macrophages were stimulated with apoptotic cells for 30 minutes and whole 
cell lysates were blotted for phopsho-Akt.  Blots were stripped and reprobed for total Akt. 
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Figure 3.5 Axl, Mertk, or Tyro3 are not required for downregulation of pro-
inflammatory cytokines in response to apoptotic cells. A) LPS B) PGN, or C) Zymosan 
titration in micrograms on wild-type and knockout macrophages.  Macrophages were 
stimulated for 3 or 18 hours and then supernatants were analyzed for TNF-alpha secretion. 
D) 1.0 ug/ml of LPS was used to stimulate macrophages in the presence of increasing 
concentrations of apoptotic cells.  Fold increase (#X) represents number of apoptotic cells 
(apop) per macrophage.  Supernatants were collected after 18 hours.  E) TNF-alpha or F) 
TGF-beta relative RNA levels measured using RPA. Values were normalized to GAPDH in 
each sample.  Error bars represent standard error. This data is representative of three 
experiments. 
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The phagocytosis of apoptotic cells is paramount for the maintenance of a number of 
physiologic processes including immune homeostasis.  Although a large number of receptors, 
opsonins, and binding sites on apoptotic cells have been proposed to be involved in this 
process it is unclear how these receptors operate on various cell types and what their in vivo 
function is.  Studies examining receptors on multiple cell types may provide insights to how 
different phagocytes recognize and engulf apoptotic cells and whether rates of phagocytosis 
has alteration in biological processes.  The inability to phagocytose apoptotic cells has clear 
consequences, as a deficit in clearance has been linked to developmental abnormalities and 
survival, to organ dysfunction, and to autoantibody production and autoimmune disease.  
This process is conserved among flies, worms, mice, and humans which further illustrates the 
importance of examining the cellular and molecular mechanisms.   
Our data demonstrates the importance of the Axl/Mertk/Tyro3 family of receptor 
tyrosine kinases in the clearance of apoptotic cells by both macrophages and dendritic cells.  
Previous reports indicated that Mertk was critical for the engulfment of apoptotic cells by 
macrophages but this receptor played no role in dendritic cell phagocytosis(28, 46).  The 
difference in phagocytosis by macrophages versus dendritic cells has now been explained by 
experiments elaborated in Chapter 2.  In studies here with the single and double knockout 
mice, the function of apoptotic cell engulfment can now include Axl and Tyro3 family 
members.  Interestingly, the combinatorial usage of the three receptor tyrosine kinases is 
different in macrophages and dendritic cells.  Specifically, macrophages from axl-/-, tyro3-/-,
and axl/tyro3-/- mice have an ~50% reduction in phagocytosis of apoptotic cells (Figure 2.1).  
While this is a significant decrease in phagocytosis compared with wild type, it is not as 
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dramatic as the deficit in phagocytosis of apoptotic cells seen in the macrophages from 
mertkkd mice.   Nonetheless, macrophages appear to utilize all three Axl/Mertk/Tyro3 
receptor family members for engulfment.  
While macrophages may be the most efficient cell type at phagocytosing apoptotic 
cells, dendritic cells also play an important role in the phagocytosis of apoptotic cells.   
Similar to previous findings(28, 46, 121), we found that dendritic cells from mertkkd mice had 
no defect in phagocytosis compared with wild type; however, dendritic cells from axl-/-,
tyro3-/-, and axl/tyro3-/- mice had a complete deficit in phagocytosis of apoptotic cells (Figure 
2.2). Although dendritic cells express Mertk, it is puzzling why there is a partition of function 
and suggests a second role for Mertk that may be more critical for dendritic cells such as 
cytokine regulation. This is the first demonstration that Axl and Tyro3 functions in 
engulfment of apoptotic cells and that murine dendritic cells rely solely on these two 
receptors.   
In order to better understand the differences in receptor usage between macrophages 
and dendritic cells, we examined whether the two ligands for this receptor family, GAS6 and 
Protein S, were expressed differently among cell types.  The ligands for Axl, Mertk, and 
Tyro3 are expressed differently on macrophages versus dendritic cells.  While both ligands, 
GAS6 and Protein S, are ubiquitously found in the serum of normal mice, the concentration 
of these ligands in the local microenvironment may be greater and could provide the 
necessary threshold to promote receptor engagement and activation.  We found through RT-
PCR, that macrophages express both GAS6 and Protein S, while dendritic cells express only 
Protein S (Figure 2.3b).  This may help to explain why macrophages are more efficient 
phagocytes, as they have GAS6 which can bind to each receptor and Protein S which binds 
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strongly to Tyro3 available.  The combination of engaging multiple receptors may trigger 
signal transduction particularly through Mertk which is the major trigger for engulfment.   
Another interesting observation on the differences between macrophages and 
dendritic cells is their surface receptor expression.  We found that while macrophages and 
dendritic cells both express all three receptors, the level of receptor expression on 
macrophages was higher than that seen in dendritic cells (Figure 2.3c-h).  While there were 
no differences in expression between Axl, Mertk, or Tyro3, the fact that dendritic cells have 
less surface expression of these receptors could explain why they are slower at ingesting 
apoptotic cells compared with macrophages.  The lower level of receptor available for 
engagement would be consistent with poorer signaling for phagocytosis.  Furthermore, each 
receptor may have inherent differences in their ability to trigger phagocytosis i.e. Mertk may 
be the most prominent receptor; however, studies were not conducted to compare Axl or 
Tyro3. 
Previous reports in collaboration with Lemke’s laboratory described the presence of 
apoptotic bodies throughout the triple Axl/Mertk/Tyro3 knock out mice without knowing a 
reason for the widespread observations(27).  Our laboratory reported the mechanism was due 
to Mertk functioning as a recognition and phagocytosis receptor specifically for apoptotic 
cells and not other particles(28).  To understand the role Axl, Mertk, and Tyro3 play in vivo,
we looked at thymus, retina, and spleen.  We found that in the thymus, while mertkkd mice 
were significantly unable to clear apoptotic cells compared with wild type, there were no 
differences in axl-/-, tyro3-/-, or axl/tyro3-/- mice (Figure 2.4).  This suggests that in the 
thymus, Mertk plays an important role in clearance, whereas Axl and Tyro3 do not.  The cell 
type responsible for clearance in thymus is unknown, although macrophages and dendritic 
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cells are abundant in this tissue.  We therefore expected to see a partial deficit in mice 
lacking Axl, Tyro3, or both.  A possible explanation lies in the fact that under normal 
unstimulated conditions, the thymus in all genotypes, including mertkkd has no appreciable 
defect in clearance.  Therefore, the compensation mechanisms in the thymus are highly 
redundant and efficient, which could account for the ability of axl-/-, tyro3-/-, and axl/tyro3-/- 
mice to clear apoptotic cells normally due to the presence of Mertk.  This assumption is 
reasonable in an organ in which 99 percent of the thymocytes undergo apoptosis and the 
swift removal of apoptotic debris is important to maintain proper tissue homeostasis.  
Furthermore, while the axl-/-, tyro3-/-, and axl/tyro3-/- mice are able to compensate, the 
macrophages in mertkkd mice do not have adequate compensation by other receptors or other 
cell types; hence the dramatic deficits in its absence.   
Similar to the thymus, we examined the retina of the Axl and Tyro3 knockout animals 
as it has been previously established that mertkkd mice are blind due to the retinal pigment 
epithelia’s inability to phagocytose shed outer segments.  We therefore thought it was 
important to examine the role of Axl and Tyro3 in the retina.  In contrast to mertkkd we found 
that there was no evidence of retinal degeneration in mice lacking axl, tyro3, and axl/tyro3 
which was compared with wild type (Figure 2.5).  This demonstrates another organ where 
Mertk is critical, yet Axl and Tyro3 are not.  Recent reports demonstrate Tyro3 but not Axl 
expression in addition to Mertk on retinal pigment epithelium(91).  This report also shows 
that in mice lacking mertk there is lower expression of Tyro3 on the retinal pigment 
epithelium, and that Mertk can be phosphorylated by stimulation with Protein S, which is 
only thought to stimulate Tyro3.  A previous report on rat RPE also suggested that Mertk was 
the critical receptor and found similar results that GAS6 and Protein S could promote 
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phagocytosis(112).  This is interesting data to consider; however our finding of normal retina 
tissue in mice lacking Tyro3 refutes the importance of Tyro3 on retinal pigment epithelium 
or it suggests that an alternative mechanism can lead to the phosphorylation of Mertk.  It is 
plausible the integrins on RPE might interact with Mertk and further studies to look closely 
at Mertk function in the absence of Tyro3 are warranted.   
A third organ we examined in looking at in vivo function of these receptors was the 
spleen.  This organ was chosen because of the large number of lymphocytes that undergo 
expansion and contraction and blood flow that must be maintained.  We found that opposite 
of what is observed in the thymus mice lacking axl/tyro3 had a significant defect in the 
clearance of an apoptotic cell burden in the spleen compared with wild type.  Mice deficient 
in MFG-E8, a ligand for integrins, was also shown to prevent proper phagocytosis of KLH-
stimulated lymphocytes in the spleen.  Interestingly, while mertkkd mice had higher levels of 
apoptotic cells they were not significant. In addition, the spleen is the first organ where lack 
of axl or lack of tyro3 is additive in the axl/tyro3 double knockout (Figure 2.7).  One 
conclusion from this data is that in the spleen, dendritic cells along with macrophages are 
highly abundant and it is the dendritic cells that come in contact initially with the apoptotic B 
cells in this model.  Perhaps the complete inability of dendritic cells and partial defect seen in 
macrophages in mice lacking axl/tyro3 overwhelms the system leading to uncleared 
persistent apoptotic cells.  We do not know however, which cell type is ingesting the 
apoptotic cells, and therefore it is difficult to speculate on mechanism in the spleen.  
Conditional knockout of each Axl/Mertk/Tyro3 receptor in either macrophages or dendritic 
cells may provide insights as which cell type is contributing to the clearance in the spleen. 
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Evidence from studies in platelets and retina suggest that association of the three 
receptors is required for optimal function.  Because we see a dramatic defect in macrophages 
from mertkkd mice, we wanted to examine first the role of Mertk in both wild type and 
axl/tyro3-/- mice.  We found that Mertk was phosphorylated upon stimulation of apoptotic 
cells only in wild type macrophages (Figure 2.6).  We detected no Mertk phosphorylation 
with a phospho-specific antibody (data not shown) or a global phosphotyrosine antibody after 
Mertk immunoprecipitations in macrophages from mice lacking Axl and Tyro3 (Figure 2.6).  
This suggests that association of Axl or Tyro3 receptors with Mertk is required for optimal 
activation of Mertk.  And while we cannot rule out that there was a low undetectable level of 
Mertk phosphorylation in macrophages from mice lacking axl and tyro3, it supports the 
defect in phagocytosis observed in these mice.  
In addition to published reports, our data suggests that Axl, Mertk, and Tyro3 
cooperate together to mediate efficient phagocytosis of apoptotic cells.  While extensive 
studies have been done examining the affinity of GAS6 for each receptor, there has been 
little study on how Protein S binds.  What is currently known is that Protein S binds only to 
Tyro3. We have demonstrated that murine Protein S binds to murine Tyro3, which had not 
been demonstrated previously (Figure 2.5).  Both Protein S and GAS6 have been shown to 
bind apoptotic cells as well, therefore our hypothesis is that these ligands serve to opsonize 
the apoptotic cell and promote recognition and binding with the Axl, Mertk, and Tyro3 
receptors on phagocytes.   Although there is strong evidence to suggest this link, there is no 
direct evidence of Axl, Mertk, or Tyro3 binding to the surface of an apoptotic cell, through a 
ligand or not.  Therefore we sought to examine in Chapter 3, the ability of extracellular 
domains of these receptors to bind to the apoptotic cell, in the presence of normal mouse 
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serum.  We found that Tyro3 constructs had the highest percent of bound apoptotic cells, this 
was followed by Axl and Mertk (Figure 3.1).  This data is consistent with the ligand-binding  
data suggesting that Mertk and Axl can only utilize GAS6.  Tyro3, which has been shown to 
have the greater affinity for GAS6 among the receptor family members, was the best binder. 
In addition to binding through GAS6, Tyro3 has the ability to use Protein S that can bind to 
phosphatidylserine on apoptotic cells and can weakly trigger phagocytosis alone or possibly 
help activate Mertk for a stronger response.  While these experiments did demonstrate 
binding to the apoptotic cell, the percentage of cells with bound receptor was low.  We 
expected to see numbers similar to the number of Annexin V positive cells in the population 
(~80%).   Annexin V binds to phosphatidylserine, the proposed binding site of both Protein S 
and GAS6.  This could be due to the in vitro nature of the assay, or having the Fc chimeric 
receptor constructs, secondary antibody or ligand not in optimum levels.  Further titrations of 
these reagents will aid in resolving this issue.  
Another method to address the role each ligand and receptor plays in the phagocytosis 
of apoptotic cells is to block the interaction using specific antibodies.  This technique has 
been used in many other systems including CD14, C1q, and Scavenger Receptor binding(38, 
39, 102).  We therefore utilized commercially available antibodies to GAS6, Protein S, Axl, 
Mertk, and Tyro3 to block interactions of phagocytes with apoptotic cells.  Unfortunately, we 
saw no appreciable blocking with any antibody used (Figure 3.1).  This makes interpretation 
difficult, as the antibodies used were polyclonal and therefore the specificity of the epitopes 
of these antibodies is unknown, as is the abundance of antibodies specific for any one 
epitope.  Therefore we cannot make any definitive conclusions based on these antibody-
blocking studies. 
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An alternative way to block receptor binding is to use a decoy receptor.  We utilized 
the Axl-Fc, Mertk-Fc, or Tyro3-Fc chimera constructs to hopefully absorb all available 
ligands in cultures or occupy the binding sights of ligand to prevent phagocytosis of 
apoptotic cells.  While the intention of the assay was to block interaction, only a modest 
blocking was observed using Axl-Fc and Mertk-Fc constructs, however the Tyro3-Fc 
chimera actually enhanced phagocytosis (Figure 3.1).   One theory to explain this data is that 
Tyro3 is binding preferentially to the apoptotic cell and acting to opsonized the cell with Fc 
regions.  This would cause enhanced phagocytosis, as Fc receptor-mediated phagocytosis is 
highly efficient in macrophages and independent of Mertk.  To test this theory, we blocked 
Fc receptor-mediated phagocytosis with an antibody to the Fc
 receptor (Figure 3.1).  This 
effectively blocked the enhancement of phagocytosis that we saw with Tyro3-Fc chimera 
indicating that this construct was acting non-specifically through Fc receptor-mediated 
phagocytosis.  One conclusion that can be drawn from this data is that Tyro3 binds to the 
apoptotic cell better than Axl or Mertk, as was demonstrated when the binding was analyzed 
by flow cytometry.  This conclusion assumes that all constructs were comparably made and 
proteins were all folded properly to allow for similar ligand binding.   In addition, this 
conclusion assumes that the Fc portion of each chimera construct is equally able to bind and 
activate the Fc Receptor complex.  Because of these assumptions, binding and blocking 
experiments using non-Fc chimeric molecules is necessary.  While cell lines producing these 
molecules have been generated, the proteins still need to be purified, quantified, and tested 
for ligand binding. 
An additional piece of evidence to demonstrate interaction among the family 
members is that they are expressed on the same cell.  Previous surface staining has only been 
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done using single receptors.  This is because each of the commercially available antibodies 
are only available unconjugated to fluorochromes and all are prepared in goats, limiting the 
usable repertoire of secondary antibodies to identify each receptor singly.  Attempts to label 
the antibodies to fluorochromes ourselves have been largely unsuccessful.   The only 
antibody we have shown to be labeled and maintain specificity is the anti-Mertk antibody 
conjugated to Alexa Fluor-555.  Using this antibody we show that Axl and Mertk are 
expressed on the same macrophage (Figure 3.2).  Unfortunately no private or commercially 
available antibody to Tyro3 exists that demonstrates specificity in staining.   
To examine directly at the ability of these receptors to associate we used 
immunoprecipitation experiments.  We again ran into challenges with specificity of 
commercial antibodies, and therefore utilized cell lines transiently transfected with tagged 
constructs.  We found no detectable association between the receptors (Figure 3.2).  While 
this data suggests that no interaction exists, we still cannot rule out a transient association, or 
perhaps another intermediate that is associating with multiple receptors.  Studies using cross-
linking agents will help us better understand if there is a transient association and how close 
the receptors might be on the cell surface; however, initial attempts have not revealed 
binding partners. 
The literature suggests that Mertk associates with Vav1 and/or v5 integrin during 
activation, and that this interaction is critical for Mertk phagocytosis function(116, 118).  
This previous work was done in transfected cell lines, with overexpressed constructs.  
Therefore, it was important to understand if these mechanisms were an artifact of 
experimental conditions or whether such associations exist in primary cells. In primary 
macrophages, Mertk associates with Vav1 but not v5 (Figure 3.3).  Our data differs from 
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published results in that Mertk does not constitutively associate with Vav1 in resting primary 
macrophages. Thus, we saw no association in unstimulated macrophages, and a transient 
binding and release of Vav1 at 15 and 30 minutes respectively.  This is consistent with the 
literature demonstrating a role for Vav1 in actin remodeling for engulfment(116).   
Further studies need to be done to prove or eliminate an association with integrins. 
They have been shown to be involved in phagocytosis in multiple cell types including RPE 
and transfected cell lines. It has been suggested that cytoskeletal rearrangements are 
dependent on cooperation of integrin and Mertk to trigger phosphorylation and to induce 
phagocytosis(118).  These experiments would include looking at other integrins such as v3, 
using crosslinking agents to detect any transient associations and look at the effect of 
stimulation of integrins with MFG-E8, which is a ligand that has been demonstrated to 
trigger phagocytosis of apoptotic cells.   
The binding of the apoptotic cell and the downstream signaling must occur to trigger 
phagocytosis. A known signaling protein in this pathway, FAK, has been demonstrated to be 
downstream of integrin signaling and activated by Mertk.  We saw lower FAK 
phosphorylation levels in tyro3-/- and axl/tyro3-/- macrophages compared with wild type 
suggesting a deficit in FAK activation (Figure 3.4). This may be due to the lower level of 
Mertk phosphorylation in these cells, as previous work showed Mertk phosphorylation 
directly affecting FAK phosphorylation in cell lines.  This need for Mertk phosphorylation by 
Tyro3 or phosphorylation of integrins has been implied in our study and others(27, 91).  
Thus, the interactions and phosphorylation events that trigger receptor family members 
requires further investigation and the development of additional reagents will facilitate future 
studies. 
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While multiple points along the signaling pathway suggest a role for Axl, Mertk, and 
Tyro3 in signaling for engulfment of apoptotic cells another critical feature of this process is 
the downregulation of cytokines.  Mertk has been previously demonstrated to be required to 
down regulate NF-kB upon LPS stimulation in an endotoxic shock model(82).  Akt is 
upstream of NF-kB activation and is phosphorylated upon apoptotic cell stimulation(121).  
We saw no difference in phospho-Akt levels or downregulation of cytokines in macrophages 
from mertkkd or axl/tyro3-/- mice compared with wild type (Figure 3.4b and 3.5).  This was 
examined using multiple PAMPs and multiple titrations and ratios of apoptotic cells.  This 
data suggesting a lack of suppression of cytokines was also confirmed using both RNA and 
protein assessments.  Our results demonstrates that in macrophages, Mertk, Axl, and Tyro3 
serve in engulfment of cells only.  In contrast, Mertk has been shown to be important in the 
downregulation of NF-kB and the reduction in IL-12(121).  Studies using triple knockout 
axl/mertk/tyro3-/- animals would be beneficial to understanding if compensation is occurring 
in single or double knockout mice used in our studies, and would definitively determine if 
each member of this family of receptors is required for downregulating proinflammatory 
cytokines. 
We remain puzzled by the differences in Mertk usage between macrophages and 
dendritic cells.  Unfortunately the commercially available antibodies to Mertk are not strong 
enough to allow detection of appreciable Mertk protein in dendritic cells; therefore 
understanding the phosphorylation status in these cells has been difficult.  We also do not 
know the expression pattern or usage of Axl, Mertk, and/or Tyro3 on cell types other than 
macrophages and dendritic cells.  Other phagocytic cell types, such as microglia, thymic 
epithelial cells, neutrophils, and osteoclasts have not been examined for expression or defects 
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in phagocytosis.  Understanding the role of Axl, Mertk, and Tyro3 in each specific cell and 
tissue type may develop a comprehensive picture of how these receptors are utilized and that 
their function may change depending on the cell type. 
Another important area of phagocytosis of apoptotic cells that is still understudied is 
the apoptotic cells themselves.  In all of our in vitro studies we have used dexamethasone-
induced apoptotic thymocytes from wild type animals.  While this choice makes sense 
biologically because of the role macrophages play in clearing thymocytes in vivo, many other 
apoptotic cell types occur in the body and are phagocytosed.  It would therefore be important 
to understand how each type of apoptotic cell and necrotic cell attract phagocytes and trigger 
their recognition and phagocytosis.  Various cell types may produce different “eat me” 
signals that we do not fully understand.  A comprehensive examination of different apoptotic 
cell types would aid in understanding which stage of apoptosis and which markers of 
apoptosis are recognized by Axl, Mertk, and Tyro3 receptors.  The regulation, signal 
transduction, and additional function of this family of receptor tyrosine kinases warrant 
further examination. 
94  
REFERENCES 
1. Franc, N. C., K. White, and R. A. Ezekowitz. 1999. Phagocytosis and development: 
back to the future. Curr Opin Immunol 11:47.
2. Morris, L., C. F. Graham, and S. Gordon. 1991. Macrophages in haemopoietic and 
other tissues of the developing mouse detected by the monoclonal antibody F4/80. 
Development 112:517.
3. Franc, N. C., J. L. Dimarcq, M. Lagueux, J. Hoffmann, and R. A. Ezekowitz. 1996. 
Croquemort, a novel Drosophila hemocyte/macrophage receptor that recognizes 
apoptotic cells. Immunity 4:431.
4. Bose, J., A. D. Gruber, L. Helming, S. Schiebe, I. Wegener, M. Hafner, M. Beales, F. 
Kontgen, and A. Lengeling. 2004. The phosphatidylserine receptor has essential 
functions during embryogenesis but not in apoptotic cell removal. J Biol 3:15.
5. Kunisaki, Y., S. Masuko, M. Noda, A. Inayoshi, T. Sanui, M. Harada, T. Sasazuki, 
and Y. Fukui. 2004. Defective fetal liver erythropoiesis and T lymphopoiesis in mice 
lacking the phosphatidylserine receptor. Blood 103:3362.
6. Li, M. O., M. R. Sarkisian, W. Z. Mehal, P. Rakic, and R. A. Flavell. 2003. 
Phosphatidylserine receptor is required for clearance of apoptotic cells. Science 
302:1560.
7. Wood, W., M. Turmaine, R. Weber, V. Camp, R. A. Maki, S. R. McKercher, and P. 
Martin. 2000. Mesenchymal cells engulf and clear apoptotic footplate cells in 
macrophageless PU.1 null mouse embryos. Development 127:5245.
8. Ellis, R. E., D. M. Jacobson, and H. R. Horvitz. 1991. Genes required for the 
engulfment of cell corpses during programmed cell death in Caenorhabditis elegans. 
Genetics 129:79.
9. Surh, C. D., and J. Sprent. 1994. T-cell apoptosis detected in situ during positive and 
negative selection in the thymus. Nature 372:100.
10. Cook, M. C. 2004. B cell biology, apoptosis, and autoantibodies to phospholipids. 
Thromb Res 114:307.
95  
11. Gaipl, U. S., J. Brunner, T. D. Beyer, R. E. Voll, J. R. Kalden, and M. Herrmann. 
2003. Disposal of dying cells: a balancing act between infection and autoimmunity. 
Arthritis Rheum 48:6.
12. Akgul, C., D. A. Moulding, and S. W. Edwards. 2001. Molecular control of 
neutrophil apoptosis. FEBS Lett 487:318.
13. Parnaik, R., M. C. Raff, and J. Scholes. 2000. Differences between the clearance of 
apoptotic cells by professional and non-professional phagocytes. Curr Biol 10:857.
14. Gregory, C. D., and A. Devitt. 2004. The macrophage and the apoptotic cell: an 
innate immune interaction viewed simplistically? Immunology 113:1.
15. Savill, J. 1997. Recognition and phagocytosis of cells undergoing apoptosis. Br Med 
Bull 53:491.
16. Savill, J., and C. Haslett. 1995. Granulocyte clearance by apoptosis in the resolution 
of inflammation. Semin Cell Biol 6:385.
17. Coleman, M. L., and M. F. Olson. 2002. Rho GTPase signalling pathways in the 
morphological changes associated with apoptosis. Cell Death Differ 9:493.
18. Voll, R. E., M. Herrmann, E. A. Roth, C. Stach, J. R. Kalden, and I. Girkontaite. 
1997. Immunosuppressive effects of apoptotic cells. Nature 390:350.
19. Fadok, V. A., D. L. Bratton, A. Konowal, P. W. Freed, J. Y. Westcott, and P. M. 
Henson. 1998. Macrophages that have ingested apoptotic cells in vitro inhibit 
proinflammatory cytokine production through autocrine/paracrine mechanisms 
involving TGF-beta, PGE2, and PAF. J Clin Invest 101:890.
20. Fadok, V. A., P. P. McDonald, D. L. Bratton, and P. M. Henson. 1998. Regulation of 
macrophage cytokine production by phagocytosis of apoptotic and post-apoptotic 
cells. Biochem Soc Trans 26:653.
21. Aderem, A., and D. M. Underhill. 1999. Mechanisms of phagocytosis in 
macrophages. Annu Rev Immunol 17:593.
96  
22. Bladon, J., and P. C. Taylor. 2006. Extracorporeal photopheresis: a focus on 
apoptosis and cytokines. J Dermatol Sci 43:85.
23. Devitt, A., K. G. Parker, C. A. Ogden, C. Oldreive, M. F. Clay, L. A. Melville, C. O. 
Bellamy, A. Lacy-Hulbert, S. C. Gangloff, S. M. Goyert, and C. D. Gregory. 2004. 
Persistence of apoptotic cells without autoimmune disease or inflammation in CD14-
/- mice. J Cell Biol 167:1161.
24. Botto, M., C. Dell'Agnola, A. E. Bygrave, E. M. Thompson, H. T. Cook, F. Petry, M. 
Loos, P. P. Pandolfi, and M. J. Walport. 1998. Homozygous C1q deficiency causes 
glomerulonephritis associated with multiple apoptotic bodies. Nat Genet 19:56.
25. Mitchell, D. A., M. C. Pickering, J. Warren, L. Fossati-Jimack, J. Cortes-Hernandez, 
H. T. Cook, M. Botto, and M. J. Walport. 2002. C1q deficiency and autoimmunity: 
the effects of genetic background on disease expression. J Immunol 168:2538.
26. Hanayama, R., M. Tanaka, K. Miyasaka, K. Aozasa, M. Koike, Y. Uchiyama, and S. 
Nagata. 2004. Autoimmune disease and impaired uptake of apoptotic cells in MFG-
E8-deficient mice. Science 304:1147.
27. Lu, Q., and G. Lemke. 2001. Homeostatic regulation of the immune system by 
receptor tyrosine kinases of the Tyro 3 family. Science 293:306.
28. Scott, R. S., E. J. McMahon, S. M. Pop, E. A. Reap, R. Caricchio, P. L. Cohen, H. S. 
Earp, and G. K. Matsushima. 2001. Phagocytosis and clearance of apoptotic cells is 
mediated by MER. Nature 411:207.
29. Potter, P. K., J. Cortes-Hernandez, P. Quartier, M. Botto, and M. J. Walport. 2003. 
Lupus-prone mice have an abnormal response to thioglycolate and an impaired 
clearance of apoptotic cells. J Immunol 170:3223.
30. Qian, Y., K. L. Conway, X. Lu, H. M. Seitz, G. K. Matsushima, and S. H. Clarke. 
2006. Autoreactive MZ and B-1 B-cell activation by Faslpr is coincident with an 
increased frequency of apoptotic lymphocytes and a defect in macrophage clearance. 
Blood 108:974.
31. Tas, S. W., P. Quartier, M. Botto, and L. Fossati-Jimack. 2006. Macrophages from 
patients with SLE and rheumatoid arthritis have defective adhesion in vitro, while 
only SLE macrophages have impaired uptake of apoptotic cells. Ann Rheum Dis 
65:216.
97  
32. Hermann, J. A., M. A. Hall, R. N. Maini, M. Feldmann, and F. M. Brennan. 1998. 
Important immunoregulatory role of interleukin-11 in the inflammatory process in 
rheumatoid arthritis. Arthritis Rheum 41:1388.
33. Hanayama, R., M. Tanaka, K. Miwa, A. Shinohara, A. Iwamatsu, and S. Nagata. 
2002. Identification of a factor that links apoptotic cells to phagocytes. Nature 
417:182.
34. Nakano, T., Y. Ishimoto, J. Kishino, M. Umeda, K. Inoue, K. Nagata, K. Ohashi, K. 
Mizuno, and H. Arita. 1997. Cell adhesion to phosphatidylserine mediated by a 
product of growth arrest-specific gene 6. J Biol Chem 272:29411.
35. Anderson, H. A., C. A. Maylock, J. A. Williams, C. P. Paweletz, H. Shu, and E. 
Shacter. 2003. Serum-derived protein S binds to phosphatidylserine and stimulates 
the phagocytosis of apoptotic cells. Nat Immunol 4:87.
36. Luciani, M. F., and G. Chimini. 1996. The ATP binding cassette transporter ABC1, is 
required for the engulfment of corpses generated by apoptotic cell death. Embo J 
15:226.
37. Platt, N., R. P. da Silva, and S. Gordon. 1998. Recognizing death: the phagocytosis of 
apoptotic cells. Trends Cell Biol 8:365.
38. Devitt, A., O. D. Moffatt, C. Raykundalia, J. D. Capra, D. L. Simmons, and C. D. 
Gregory. 1998. Human CD14 mediates recognition and phagocytosis of apoptotic 
cells. Nature 392:505.
39. Ogden, C. A., A. deCathelineau, P. R. Hoffmann, D. Bratton, B. Ghebrehiwet, V. A. 
Fadok, and P. M. Henson. 2001. C1q and mannose binding lectin engagement of cell 
surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic 
cells. J Exp Med 194:781.
40. Gardai, S. J., K. A. McPhillips, S. C. Frasch, W. J. Janssen, A. Starefeldt, J. E. 
Murphy-Ullrich, D. L. Bratton, P. A. Oldenborg, M. Michalak, and P. M. Henson. 
2005. Cell-surface calreticulin initiates clearance of viable or apoptotic cells through 
trans-activation of LRP on the phagocyte. Cell 123:321.
41. Savill, J., N. Hogg, Y. Ren, and C. Haslett. 1992. Thrombospondin cooperates with 
CD36 and the vitronectin receptor in macrophage recognition of neutrophils 
undergoing apoptosis. J Clin Invest 90:1513.
98  
42. Eda, S., M. Yamanaka, and M. Beppu. 2004. Carbohydrate-mediated phagocytic 
recognition of early apoptotic cells undergoing transient capping of CD43 
glycoprotein. J Biol Chem 279:5967.
43. Rovere, P., G. Peri, F. Fazzini, B. Bottazzi, A. Doni, A. Bondanza, V. S. 
Zimmermann, C. Garlanda, U. Fascio, M. G. Sabbadini, C. Rugarli, A. Mantovani, 
and A. A. Manfredi. 2000. The long pentraxin PTX3 binds to apoptotic cells and 
regulates their clearance by antigen-presenting dendritic cells. Blood 96:4300.
44. Nauta, A. J., B. Bottazzi, A. Mantovani, G. Salvatori, U. Kishore, W. J. Schwaeble, 
A. R. Gingras, S. Tzima, F. Vivanco, J. Egido, O. Tijsma, E. C. Hack, M. R. Daha, 
and A. Roos. 2003. Biochemical and functional characterization of the interaction 
between pentraxin 3 and C1q. Eur J Immunol 33:465.
45. Taylor, P. R., A. Carugati, V. A. Fadok, H. T. Cook, M. Andrews, M. C. Carroll, J. S. 
Savill, P. M. Henson, M. Botto, and M. J. Walport. 2000. A hierarchical role for 
classical pathway complement proteins in the clearance of apoptotic cells in vivo. J
Exp Med 192:359.
46. Cohen, P. L., R. Caricchio, V. Abraham, T. D. Camenisch, J. C. Jennette, R. A. 
Roubey, H. S. Earp, G. Matsushima, and E. A. Reap. 2002. Delayed apoptotic cell 
clearance and lupus-like autoimmunity in mice lacking the c-mer membrane tyrosine 
kinase. J Exp Med 196:135.
47. Christiansen-Weber, T. A., J. R. Voland, Y. Wu, K. Ngo, B. L. Roland, S. Nguyen, P. 
A. Peterson, and W. P. Fung-Leung. 2000. Functional loss of ABCA1 in mice causes 
severe placental malformation, aberrant lipid distribution, and kidney 
glomerulonephritis as well as high-density lipoprotein cholesterol deficiency. Am J 
Pathol 157:1017.
48. Rescigno, J., A. Mansukhani, and C. Basilico. 1991. A putative receptor tyrosine 
kinase with unique structural topology. Oncogene 6:1909.
49. O'Bryan, J. P., R. A. Frye, P. C. Cogswell, A. Neubauer, B. Kitch, C. Prokop, R. 
Espinosa, 3rd, M. M. Le Beau, H. S. Earp, and E. T. Liu. 1991. axl, a transforming 
gene isolated from primary human myeloid leukemia cells, encodes a novel receptor 
tyrosine kinase. Mol Cell Biol 11:5016.
50. Janssen, J. W., A. S. Schulz, A. C. Steenvoorden, M. Schmidberger, S. Strehl, P. F. 
Ambros, and C. R. Bartram. 1991. A novel putative tyrosine kinase receptor with 
oncogenic potential. Oncogene 6:2113.
99  
51. Wimmel, A., D. Glitz, A. Kraus, J. Roeder, and M. Schuermann. 2001. Axl receptor 
tyrosine kinase expression in human lung cancer cell lines correlates with cellular 
adhesion. Eur J Cancer 37:2264.
52. Vajkoczy, P., P. Knyazev, A. Kunkel, H. H. Capelle, S. Behrndt, H. von Tengg-
Kobligk, F. Kiessling, U. Eichelsbacher, M. Essig, T. A. Read, R. Erber, and A. 
Ullrich. 2006. Dominant-negative inhibition of the Axl receptor tyrosine kinase 
suppresses brain tumor cell growth and invasion and prolongs survival. Proc Natl 
Acad Sci U S A 103:5799.
53. Berclaz, G., H. J. Altermatt, V. Rohrbach, I. Kieffer, E. Dreher, and A. C. Andres. 
2001. Estrogen dependent expression of the receptor tyrosine kinase axl in normal 
and malignant human breast. Ann Oncol 12:819.
54. Ito, T., M. Ito, S. Naito, A. Ohtsuru, Y. Nagayama, T. Kanematsu, S. Yamashita, and 
I. Sekine. 1999. Expression of the Axl receptor tyrosine kinase in human thyroid 
carcinoma. Thyroid 9:563.
55. Jacob, A. N., J. Kalapurakal, W. R. Davidson, G. Kandpal, N. Dunson, Y. Prashar, 
and R. P. Kandpal. 1999. A receptor tyrosine kinase, UFO/Axl, and other genes 
isolated by a modified differential display PCR are overexpressed in metastatic 
prostatic carcinoma cell line DU145. Cancer Detect Prev 23:325.
56. TBudagian, V., E. Bulanova, Z. Orinska, L. Thon, U. Mamat, P. Bellosta, C. Basilico, 
D. Adam, R. Paus, and S. Bulfone-Paus. 2005. A promiscuous liaison between IL-15 
receptor and Axl receptor tyrosine kinase in cell death control. Embo J 24:4260.
57. McCloskey, P., Y. W. Fridell, E. Attar, J. Villa, Y. Jin, B. Varnum, and E. T. Liu. 
1997. GAS6 mediates adhesion of cells expressing the receptor tyrosine kinase Axl. J
Biol Chem 272:23285.
58. Bellosta, P., M. Costa, D. A. Lin, and C. Basilico. 1995. The receptor tyrosine kinase 
ARK mediates cell aggregation by homophilic binding. Mol Cell Biol 15:614.
59. Schmidt, M., J. Muller, J. Proba, G. Ehninger, and A. Neubauer. 2000. Transfection 
of receptor tyrosine kinase axl into human haematopoietic cells does not cause 
spontaneous cellular aggregation. Br J Haematol 110:1004.
60. Costa, M., P. Bellosta, and C. Basilico. 1996. Cleavage and release of a soluble form 
of the receptor tyrosine kinase ARK in vitro and in vivo. J Cell Physiol 168:737.
100  
61. Varnum, B. C., C. Young, G. Elliott, A. Garcia, T. D. Bartley, Y. W. Fridell, R. W. 
Hunt, G. Trail, C. Clogston, R. J. Toso, and et al. 1995. Axl receptor tyrosine kinase 
stimulated by the vitamin K-dependent protein encoded by growth-arrest-specific 
gene 6. Nature 373:623.
62. D'Arcangelo, D., V. Ambrosino, M. Giannuzzo, C. Gaetano, and M. C. Capogrossi. 
2006. Axl receptor activation mediates laminar shear stress anti-apoptotic effects in 
human endothelial cells. Cardiovasc Res 71:754.
63. Gallicchio, M., S. Mitola, D. Valdembri, R. Fantozzi, B. Varnum, G. C. Avanzi, and 
F. Bussolino. 2005. Inhibition of vascular endothelial growth factor receptor 2-
mediated endothelial cell activation by Axl tyrosine kinase receptor. Blood 105:1970.
64. Melaragno, M. G., M. E. Cavet, C. Yan, L. K. Tai, Z. G. Jin, J. Haendeler, and B. C. 
Berk. 2004. Gas6 inhibits apoptosis in vascular smooth muscle: role of Axl kinase 
and Akt. J Mol Cell Cardiol 37:881.
65. Korshunov, V. A., A. M. Mohan, M. A. Georger, and B. C. Berk. 2006. Axl, a 
receptor tyrosine kinase, mediates flow-induced vascular remodeling. Circ Res 
98:1446.
66. Son, B. K., K. Kozaki, K. Iijima, M. Eto, T. Kojima, H. Ota, Y. Senda, K. Maemura, 
T. Nakano, M. Akishita, and Y. Ouchi. 2006. Statins protect human aortic smooth 
muscle cells from inorganic phosphate-induced calcification by restoring Gas6-Axl 
survival pathway. Circ Res 98:1024.
67. Budagian, V., E. Bulanova, Z. Orinska, E. Duitman, K. Brandt, A. Ludwig, D. 
Hartmann, G. Lemke, P. Saftig, and S. Bulfone-Paus. 2005. Soluble Axl is generated 
by ADAM10-dependent cleavage and associates with Gas6 in mouse serum. Mol Cell 
Biol 25:9324.
68. Hafizi, S., A. Gustafsson, J. Stenhoff, and B. Dahlback. 2005. The Ran binding 
protein RanBPM interacts with Axl and Sky receptor tyrosine kinases. Int J Biochem 
Cell Biol 37:2344.
69. Sharif, M. N., D. Sosic, C. V. Rothlin, E. Kelly, G. Lemke, E. N. Olson, and L. B. 
Ivashkiv. 2006. Twist mediates suppression of inflammation by type I IFNs and Axl. 
J Exp Med 203:1891.
101  
70. Graham, D. K., T. L. Dawson, D. L. Mullaney, H. R. Snodgrass, and H. S. Earp. 
1994. Cloning and mRNA expression analysis of a novel human protooncogene, c-
mer. Cell Growth Differ 5:647.
71. Graham, D. K., G. W. Bowman, T. L. Dawson, W. L. Stanford, H. S. Earp, and H. R. 
Snodgrass. 1995. Cloning and developmental expression analysis of the murine c-mer 
tyrosine kinase. Oncogene 10:2349.
72. Paul, S. R., D. Merberg, H. Finnerty, G. E. Morris, J. C. Morris, S. S. Jones, R. Kriz, 
K. J. Turner, and C. R. Wood. 1992. Molecular cloning of the cDNA encoding a 
receptor tyrosine kinase-related molecule with a catalytic region homologous to c-
met. Int J Cell Cloning 10:309.
73. Georgescu, M. M., K. H. Kirsch, T. Shishido, C. Zong, and H. Hanafusa. 1999. 
Biological effects of c-Mer receptor tyrosine kinase in hematopoietic cells depend on 
the Grb2 binding site in the receptor and activation of NF-kappaB. Mol Cell Biol 
19:1171.
74. Ling, L., and H. J. Kung. 1995. Mitogenic signals and transforming potential of Nyk, 
a newly identified neural cell adhesion molecule-related receptor tyrosine kinase. Mol 
Cell Biol 15:6582.
75. Evans, C. O., A. N. Young, M. R. Brown, D. J. Brat, J. S. Parks, A. S. Neish, and N. 
M. Oyesiku. 2001. Novel patterns of gene expression in pituitary adenomas identified 
by complementary deoxyribonucleic acid microarrays and quantitative reverse 
transcription-polymerase chain reaction. J Clin Endocrinol Metab 86:3097.
76. Wu, C. W., A. F. Li, C. W. Chi, C. H. Lai, C. L. Huang, S. S. Lo, W. Y. Lui, and W. 
C. Lin. 2002. Clinical significance of AXL kinase family in gastric cancer. 
Anticancer Res 22:1071.
77. Yeoh, E. J., M. E. Ross, S. A. Shurtleff, W. K. Williams, D. Patel, R. Mahfouz, F. G. 
Behm, S. C. Raimondi, M. V. Relling, A. Patel, C. Cheng, D. Campana, D. Wilkins, 
X. Zhou, J. Li, H. Liu, C. H. Pui, W. E. Evans, C. Naeve, L. Wong, and J. R. 
Downing. 2002. Classification, subtype discovery, and prediction of outcome in 
pediatric acute lymphoblastic leukemia by gene expression profiling. Cancer Cell 
1:133.
78. Ek, S., C. M. Hogerkorp, M. Dictor, M. Ehinger, and C. A. Borrebaeck. 2002. Mantle 
cell lymphomas express a distinct genetic signature affecting lymphocyte trafficking 
102  
and growth regulation as compared with subpopulations of normal human B cells. 
Cancer Res 62:4398.
79. Godowski, P. J., M. R. Mark, J. Chen, M. D. Sadick, H. Raab, and R. G. Hammonds. 
1995. Reevaluation of the roles of protein S and Gas6 as ligands for the receptor 
tyrosine kinase Rse/Tyro 3. Cell 82:355.
80. Nagata, K., K. Ohashi, T. Nakano, H. Arita, C. Zong, H. Hanafusa, and K. Mizuno. 
1996. Identification of the product of growth arrest-specific gene 6 as a common 
ligand for Axl, Sky, and Mer receptor tyrosine kinases. J Biol Chem 271:30022.
81. Ling, L., D. Templeton, and H. J. Kung. 1996. Identification of the major 
autophosphorylation sites of Nyk/Mer, an NCAM-related receptor tyrosine kinase. J
Biol Chem 271:18355.
82. Camenisch, T. D., B. H. Koller, H. S. Earp, and G. K. Matsushima. 1999. A novel 
receptor tyrosine kinase, Mer, inhibits TNF-alpha production and lipopolysaccharide-
induced endotoxic shock. J Immunol 162:3498.
83. Tschernutter, M., S. A. Jenkins, N. H. Waseem, Z. Saihan, G. E. Holder, A. C. Bird, 
S. S. Bhattacharya, R. R. Ali, and A. R. Webster. 2006. Clinical characterisation of a 
family with retinal dystrophy caused by mutation in the Mertk gene. Br J Ophthalmol 
90:718.
84. Tada, A., Y. Wada, H. Sato, T. Itabashi, M. Kawamura, M. Tamai, and K. Nishida. 
2006. Screening of the MERTK gene for mutations in Japanese patients with 
autosomal recessive retinitis pigmentosa. Mol Vis 12:441.
85. Feng, W., D. Yasumura, M. T. Matthes, M. M. LaVail, and D. Vollrath. 2002. Mertk 
triggers uptake of photoreceptor outer segments during phagocytosis by cultured 
retinal pigment epithelial cells. J Biol Chem 277:17016.
86. Duncan, J. L., H. Yang, D. Vollrath, D. Yasumura, M. T. Matthes, N. Trautmann, A. 
V. Chappelow, W. Feng, H. S. Earp, G. K. Matsushima, and M. M. LaVail. 2003. 
Inherited retinal dystrophy in Mer knockout mice. Adv Exp Med Biol 533:165.
87. Duncan, J. L., M. M. LaVail, D. Yasumura, M. T. Matthes, H. Yang, N. Trautmann, 
A. V. Chappelow, W. Feng, H. S. Earp, G. K. Matsushima, and D. Vollrath. 2003. An 
RCS-like retinal dystrophy phenotype in mer knockout mice. Invest Ophthalmol Vis 
Sci 44:826.
103  
88. Lai, C., M. Gore, and G. Lemke. 1994. Structure, expression, and activity of Tyro 3, a 
neural adhesion-related receptor tyrosine kinase. Oncogene 9:2567.
89. Lewis, P. M., K. E. Crosier, C. R. Wood, and P. S. Crosier. 1996. Analysis of the 
murine Dtk gene identifies conservation of genomic structure within a new receptor 
tyrosine kinase subfamily. Genomics 31:13.
90. Crosier, P. S., S. A. Freeman, D. Orlic, D. M. Bodine, and K. E. Crosier. 1996. The 
Dtk receptor tyrosine kinase, which binds protein S, is expressed during 
hematopoiesis. Exp Hematol 24:318.
91. Prasad, D., C. V. Rothlin, P. Burrola, T. Burstyn-Cohen, Q. Lu, P. Garcia de Frutos, 
and G. Lemke. 2006. TAM receptor function in the retinal pigment epithelium. Mol 
Cell Neurosci 33:96.
92. Stitt, T. N., G. Conn, M. Gore, C. Lai, J. Bruno, C. Radziejewski, K. Mattsson, J. 
Fisher, D. R. Gies, P. F. Jones, and et al. 1995. The anticoagulation factor protein S 
and its relative, Gas6, are ligands for the Tyro 3/Axl family of receptor tyrosine 
kinases. Cell 80:661.
93. Evenas, P., B. Dahlback, and P. Garcia de Frutos. 2000. The first laminin G-type 
domain in the SHBG-like region of protein S contains residues essential for activation 
of the receptor tyrosine kinase sky. Biol Chem 381:199.
94. Katagiri, M., Y. Hakeda, D. Chikazu, T. Ogasawara, T. Takato, M. Kumegawa, K. 
Nakamura, and H. Kawaguchi. 2001. Mechanism of stimulation of osteoclastic bone 
resorption through Gas6/Tyro 3, a receptor tyrosine kinase signaling, in mouse 
osteoclasts. J Biol Chem 276:7376.
95. Lu, Q., M. Gore, Q. Zhang, T. Camenisch, S. Boast, F. Casagranda, C. Lai, M. K. 
Skinner, R. Klein, G. K. Matsushima, H. S. Earp, S. P. Goff, and G. Lemke. 1999. 
Tyro-3 family receptors are essential regulators of mammalian spermatogenesis. 
Nature 398:723.
96. Caraux, A., Q. Lu, N. Fernandez, S. Riou, J. P. Di Santo, D. H. Raulet, G. Lemke, 
and C. Roth. 2006. Natural killer cell differentiation driven by Tyro3 receptor 
tyrosine kinases. Nat Immunol 7:747.
104  
97. Gould, W. R., S. M. Baxi, R. Schroeder, Y. W. Peng, R. J. Leadley, J. T. Peterson, 
and L. A. Perrin. 2005. Gas6 receptors Axl, Sky and Mer enhance platelet activation 
and regulate thrombotic responses. J Thromb Haemost 3:733.
98. Angelillo-Scherrer, A., L. Burnier, N. Flores, P. Savi, M. DeMol, P. Schaeffer, J. M. 
Herbert, G. Lemke, S. P. Goff, G. K. Matsushima, H. S. Earp, C. Vesin, M. F. 
Hoylaerts, S. Plaisance, D. Collen, E. M. Conway, B. Wehrle-Haller, and P. 
Carmeliet. 2005. Role of Gas6 receptors in platelet signaling during thrombus 
stabilization and implications for antithrombotic therapy. J Clin Invest 115:237.
99. Gal, A., Y. Li, D. A. Thompson, J. Weir, U. Orth, S. G. Jacobson, E. Apfelstedt-
Sylla, and D. Vollrath. 2000. Mutations in MERTK, the human orthologue of the 
RCS rat retinal dystrophy gene, cause retinitis pigmentosa. Nat Genet 26:270.
100. D'Cruz, P. M., D. Yasumura, J. Weir, M. T. Matthes, H. Abderrahim, M. M. LaVail, 
and D. Vollrath. 2000. Mutation of the receptor tyrosine kinase gene Mertk in the 
retinal dystrophic RCS rat. Hum Mol Genet 9:645.
101. de Almeida, C. J., and R. Linden. 2005. Phagocytosis of apoptotic cells: a matter of 
balance. Cell Mol Life Sci 62:1532.
102. Platt, N., H. Suzuki, T. Kodama, and S. Gordon. 2000. Apoptotic thymocyte 
clearance in scavenger receptor class A-deficient mice is apparently normal. J
Immunol 164:4861.
103. Hamon, Y., C. Broccardo, O. Chambenoit, M. F. Luciani, F. Toti, S. Chaslin, J. M. 
Freyssinet, P. F. Devaux, J. McNeish, D. Marguet, and G. Chimini. 2000. ABC1 
promotes engulfment of apoptotic cells and transbilayer redistribution of 
phosphatidylserine. Nat Cell Biol 2:399.
104. Norsworthy, P. J., L. Fossati-Jimack, J. Cortes-Hernandez, P. R. Taylor, A. E. 
Bygrave, R. D. Thompson, S. Nourshargh, M. J. Walport, and M. Botto. 2004. 
Murine CD93 (C1qRp) contributes to the removal of apoptotic cells in vivo but is not 
required for C1q-mediated enhancement of phagocytosis. J Immunol 172:3406.
105. McCutcheon, J. C., S. P. Hart, M. Canning, K. Ross, M. J. Humphries, and I. 
Dransfield. 1998. Regulation of macrophage phagocytosis of apoptotic neutrophils by 
adhesion to fibronectin. J Leukoc Biol 64:600.
105  
106. Lemke, G., and Q. Lu. 2003. Macrophage regulation by Tyro 3 family receptors. Curr 
Opin Immunol 15:31.
107. Wu, Y., N. Tibrewal, and R. B. Birge. 2006. Phosphatidylserine recognition by 
phagocytes: a view to a kill. Trends Cell Biol 16:189.
108. Tomobe, Y. I., H. Hama, T. Sakurai, A. Fujimori, Y. Abe, and K. Goto. 1996. 
Anticoagulant factor protein S inhibits the proliferation of rat astrocytes after injury. 
Neurosci Lett 214:57.
109. Beverley, S. M. 2001. Enzymatic Amplification of RNA by PCR (RT-PCR). In 
Current Protocols in Molecular Biology, Vol. 3. F. Ausubel, ed. John Wiley and 
Sons, Inc., p. 15.5.1. 
110. R. Zeller, M. R. 1993. Counterstaining and mounting of autoradiographed in situ 
hybridisation slides. In Current Protocols in Molecular Biology, Vol. 3. John Wiley 
and Sons, Inc, p. 14.5.1. 
111. Behrens, E. M., P. Gadue, S. Y. Gong, S. Garrett, P. L. Stein, and P. L. Cohen. 2003. 
The mer receptor tyrosine kinase: expression and function suggest a role in innate 
immunity. Eur J Immunol 33:2160.
112. Hall, M. O., A. L. Prieto, M. S. Obin, T. A. Abrams, B. L. Burgess, M. J. Heeb, and 
B. J. Agnew. 2001. Outer segment phagocytosis by cultured retinal pigment epithelial 
cells requires Gas6. Exp Eye Res 73:509.
113. Herrmann, M., R. E. Voll, O. M. Zoller, M. Hagenhofer, B. B. Ponner, and J. R. 
Kalden. 1998. Impaired phagocytosis of apoptotic cell material by monocyte-derived 
macrophages from patients with systemic lupus erythematosus. Arthritis Rheum 
41:1241.
114. Blander, J. M., and R. Medzhitov. 2006. On regulation of phagosome maturation and 
antigen presentation. Nat Immunol 7:1029.
115. Anderson, H. A., and E. Shacter. 2004. Natural anticoagulant proteins in the 
regulation of autoimmunity: potential role of protein S. Curr Pharm Des 10:929.
116. Mahajan, N. P., and H. S. Earp. 2003. An SH2 domain-dependent, phosphotyrosine-
independent interaction between Vav1 and the Mer receptor tyrosine kinase: a 
106  
mechanism for localizing guanine nucleotide-exchange factor action. J Biol Chem 
278:42596.
117. Akakura, S., S. Singh, M. Spataro, R. Akakura, J. I. Kim, M. L. Albert, and R. B. 
Birge. 2004. The opsonin MFG-E8 is a ligand for the alphavbeta5 integrin and 
triggers DOCK180-dependent Rac1 activation for the phagocytosis of apoptotic cells. 
Exp Cell Res 292:403.
118. Wu, Y., S. Singh, M. M. Georgescu, and R. B. Birge. 2005. A role for Mer tyrosine 
kinase in alphavbeta5 integrin-mediated phagocytosis of apoptotic cells. J Cell Sci 
118:539.
119. Bazley, L. A., and W. J. Gullick. 2005. The epidermal growth factor receptor family. 
Endocr Relat Cancer 12 Suppl 1:S17.
120. Hornstein, I., A. Alcover, and S. Katzav. 2004. Vav proteins, masters of the world of 
cytoskeleton organization. Cell Signal 16:1.
121. Sen, P., M. A. Wallet, Z. Yi, Y. Huang, M. Henderson, C. E. Mathews, H. S. Earp, G. 
Matsushima, A. S. Baldwin Jr, and R. M. Tisch. 2006. Apoptotic cells induce Mer 
tyrosine kinase-dependent blockade of NF-{kappa}B activation in dendritic cells. 
Blood.
